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Abstract 
Background: Quantifying lean tissue or muscle mass in aging and clinical populations is of 
increasing importance due to emerging associations between low muscle mass and poor physical 
function, as well as increased rates of morbidity and mortality. Lean tissue or muscle mass can be 
quantified using accurate and precise modalities, such as dual-energy x-ray absorptiometry (DXA), 
computerized tomography (CT), and magnetic resonance imaging (MRI) scans; but these modalities 
have a number of practical limitations, including limited accessibility in clinical settings for body 
composition analysis, high cost and in some cases, radiation exposure. Ultrasound is emerging as a 
modality that can accurately predict muscle mass from measures of muscle thickness and may 
circumvent many of these limitations associated with DXA, CT and MRI. Numerous ultrasound 
protocols for acquiring muscle thickness measures, such as a previously developed 9-site protocol, 
utilize several anatomical landmarks to enhance the accuracy in prediction of muscle mass. However, 
these protocols: 1) may be a time-burden for clinical staff and patients, and 2) are performed in a 
standing posture and include posterior muscle thickness measures, which may not be feasible in many 
hospitalized patients who may be less mobile. Viable bedside ultrasound protocols, such as the 4-site 
protocol (measures the quadriceps muscle thickness), have been developed and utilized in the 
intensive care unit, but have yet to comprehensively assessed for accuracy in predicting muscle mass. 
Objectives: The primary objectives of this thesis were to: 1) compare the agreement between the 4-
site ultrasound protocol and appendicular lean tissue mass measured by DXA, 2) develop an 
optimized bedside-friendly protocol to predict appendicular lean tissue, using the 4-site protocol and 
additional accessible muscle thicknesses and easily obtained covariates, and 3) assess the ability of 
the optimized ultrasound protocol to identify individuals with lower than normal lean tissue mass. 
The secondary objectives were to: 1) compare the accuracy of predicting lean tissue mass using 
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minimal and maximal compression of the 4-site protocol, 2) apply the 9-site protocol in a supine 
posture to obtain additional accessible muscle thicknesses and to compare the accuracy of lean tissue 
predictions to the 4-site and optimized ultrasound protocols, and 3) assess the reliability of the 4-site 
protocol.  
Methods: Healthy adults (≥18 years) were recruited for whole body DXA scans and ultrasound 
assessments on a single day. Whole body DXA scans were used to quantify appendicular lean tissue 
mass, the lean soft tissue in the upper and lower limbs, for each participant. Participants were 
identified as having lower than normal lean tissue if their appendicular lean tissue mass (kg) divided 
by their height (m) squared, was below previously established cut-points of 7.26 kg/m2 and 5.45 
kg/m2 for males and females respectively. The 4-site and 9-site ultrasound protocols were performed 
on participants in a supine or prone position, depending on the muscle thickness measured. The 4-site 
protocol quantifies the muscle thickness of the rectus femoris and vastus intermedialis, at the mid-
point and lower third, between the anterior superior iliac spine and the upper pole of the patella. The 
9-site protocol quantifies anterior and posterior muscle thicknesses of the upper arm, trunk, upper leg 
and lower leg and the anterior surface of the forearm. Inter-rater and intra-rater reliability of the 4-site 
protocol was performed in a subset of participants. 
Results: We recruited 96 participants (57% females), with a median (interquartile range) age of 36.5 
(24.0-72.0) years, BMI of 24.3 (22.3-27.3) kg/m2 and body fat of 30.2 (24.3-36.8) %. Significant 
differences for appendicular lean tissue mass and the 4-site muscle thicknesses were observed 
between males and females (p<0.001) and young and older adults (p<0.001). Regression analysis 
revealed a strong association between the 4-site muscle thickness and appendicular lean tissue mass, 
r2=0.72 (p<0.001), but accounting for age, sex and the additional muscle thickness of the anterior 
upper arm, improved the association to r2=0.91 (p<0.001). Using DXA based low lean tissue mass, 
18% of participants were identified as below their sex specific cut-points. The optimized ultrasound 
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protocol demonstrated a strong ability (area under the curve=0.89) to identify individuals with lower 
than normal lean tissue mass. 
Conclusions: This thesis demonstrated that a previously developed 4-site protocol strongly predicts 
appendicular lean tissue mass, but accounting for additional muscle thicknesses of the anterior upper 
arm and age and sex, greatly improves the predictive accuracy. Furthermore the optimized protocol 
strongly identifies individuals with lower than normal lean tissue mass. These results demonstrate that 
this viable bedside protocol may be useful for assessing lean tissue mass in clinical settings, but 
external validation in clinical populations is necessary to ensure the robustness of these findings.  
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Chapter 1 
Thesis Overview 
Ultrasound has been used for a number of decades to image various structures in a clinical 
setting for diagnostic purposes, but it has been undervalued in its ability to assess muscle mass. 
Ultrasound is a noninvasive, portable and safe tool to measure muscle thickness of specific muscles 
or groups of muscles (1).  Numerous protocols have been developed to quantify muscle thickness 
from multiple anatomical landmarks and have been compared against magnetic resonance imaging 
(MRI), dual-energy x-ray absorptiometry (DXA) and body densitometry for accuracy in predicting 
muscle, lean tissue or fat-free mass. However many of these ultrasound protocols are time consuming 
to conduct and are performed in standing posture, utilizing posterior muscle thicknesses, which may 
not be feasible for all clinical populations who are partially or completely immobile. Developing the 
ideal protocol to maintain accuracy, yet still be practical, is crucial in establishing ultrasound as a 
bedside tool for body composition analysis, but literature assessing the accuracy of viable bedside 
protocols in predicting muscle mass is lacking. In a clinical setting, accurately quantifying muscle 
mass and reliably tracking longitudinal changes is important in assessing risk of malnutrition or 
muscle atrophy, and determining success or failure of nutrition and/or exercise interventions. Thus, it 
is essential to assess the ability for ultrasound to predict muscle mass and identify patients with lower 
than normal muscle mass using a viable bedside protocol. Here, I compared a practical 4-site protocol 
(previously used in the intensive care unit (ICU) (2; 3), which is based on 2 bilateral sites of the 
quadriceps muscles) with regional and appendicular measures of lean tissue mass derived from DXA. 
I also evaluated other bedside accessible muscle thicknesses and easily obtainable parameters (age, 
sex, body mass index) that may optimize the current 4-site protocol in its ability to predict 
appendicular lean tissue mass. Finally, I evaluated the ability of the optimized protocol to identify 
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individuals with lower than normal lean tissue mass; these were based on previously established cut-
points for DXA scans (4). This work will build a foundation upon which future studies can aim to 
validate the use of ultrasound and develop predictive equations for lean tissue mass in specific clinical 
populations. 
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Chapter 2 
Literature Review 
2.1 Clinical importance of quantifying lean tissue  
Emerging literature has demonstrated that low lean tissue or muscle mass is associated with 
increased rates of mortality in a multitude of clinical populations (5–9). Although the association 
between mortality and lean tissue or muscle mass is an important aspect to investigate, lower than 
normal muscle mass has many other functional and clinical implications such as physical impairment, 
frailty, increased risk of falls and fractures and increased hospital length of stay and rates of 
readmission (5; 9). These negative implications of low lean tissue or muscle mass are observed in 
many populations, including diabetes (10), cancer (8; 11), chronic obstructive pulmonary disease 
(COPD) (12), liver cirrhosis (13), ICU (6; 14) and aged individuals (4; 15). Lower than normal lean 
tissue mass does not only have important implications in terms of outcomes for the patient, it also 
results in an increased cost and burden on the health care system (16; 17). Taken together, these 
factors are fundamental in the growing interest for accurately measuring or predicting lean tissue 
mass, and more specifically skeletal muscle in a clinical setting. 
2.2 Body composition modalities to assess body composition 
Lean tissue or muscle mass can be quantified from a variety of different body composition 
modalities (modalities compared in Appendix A1), such as bioelectrical impedance analysis (BIA), 
MRI, computerized tomography (CT), DXA, ultrasound, stable isotope infusions and body 
densitometry techniques. These modalities assess an individual’s body composition by utilizing 
multiple compartments at a variety of different levels (Figure 1); these compartments are based on the 
fundamental principle of the technique and mode of analysis (i.e. hydrostatic weighing to measure 
body density, which is used to estimate fat mass and fat-free mass based on previously defined 
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molecular densities). The current benchmark techniques are considered to be DXA, CT and MRI, due 
to their high accuracy and reliability in assessing lean tissue or muscle mass (5).  
Of these benchmark techniques, DXA is the more commonly used modality for body 
composition purposes in a research setting because it can provide a cost-effective whole body 
measurement of body composition with minimal radiation exposure to the participant. Originally 
developed for measuring bone mineral density in the assessment and study of osteoporosis, DXA 
scanners and software have been refined and are now widely accepted as accurate measures of body 
composition (5). DXA assesses body composition at the molecular level (Figure 1), based on a 3-
Figure 1. General overview of whole body, molecular and tissue-organ levels of body composition, the compartments 
within a given level and modalities frequently used for assessment.  
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compartment model of fat mass, lean soft tissue mass and bone mineral content. Whole body lean soft 
tissue measured using DXA includes skeletal muscles, organs, connective tissues, skin, smooth 
muscles, some bowel contents, glycogen and soft tissue minerals, and therefore cannot strictly assess 
whole body muscle mass. DXA scanners use two different energy x-rays for the analysis of body 
composition and is based on the fundamental principle of attenuation (absorption or scattering) of the 
x-ray beam as it passes through anatomical structures of different densities and thicknesses (Figure 2) 
(18). For example, low density tissues (muscle, liver, kidneys, fat) allow more photons to pass 
through (less attenuation) compared to more dense tissues (bone), where more attenuation of the x-ray 
beam occurs. The amount of attenuation between the two energy x-rays from a whole body scan, in 
conjunction with previously established attenuation coefficients for specific tissue compositions, 
Figure 2. Schematic overview of x-ray attenuation, fundamental principle of DXA scanners. 
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allows DXA to quantify fat mass, lean soft tissue and bone mineral content (19). While DXA 
measures body composition at the molecular level, many other accurate modalities, such as CT and 
MRI, evaluate body composition at the tissue-organ level, making direct comparisons difficult. 
Despite comparing different body composition levels (molecular vs. tissue-organ), DXA fat and lean 
soft tissue mass strongly associate with whole body adipose and muscle mass using CT and MRI 
scans in males, females, younger and older adults (20–23). However, DXA scans for individuals who 
are obese or have a large body thickness (>25cm), a process known as beam hardening occurs 
(increased attenuation of lower energy x-rays), which may lead to underestimation of fat mass in 
these individuals, but it is unclear if this process alters lean tissue estimations (5; 24). Therefore, 
although accurate for lean tissue estimates, body fat estimates may have to be interpreted with caution 
in obese individuals. 
A major advantage of DXA is the ability to perform regional analysis, in which the body is 
segmented into multiple sections; the most common being the left and right upper and lower limbs, 
the torso and the head. Using those body segments, lean soft tissue in the upper and lower limbs, also 
known as appendicular lean tissue mass (25), can be quantified. Appendicular lean tissue is primarily 
muscle mass (with exception of skin and connective tissues) and is strongly associated with whole 
body muscle mass measured using MRI (23). Appendicular lean tissue has therefore been an 
advantageous and a commonly used measure to assess low muscularity and its associations with poor 
physical function in older adults (4; 26; 27). These regional assessments are also crucial when 
investigating lean tissue mass in certain clinical populations, such as advanced cancer patients, in 
which visceral lean tissue compartments (liver, spleen) can become enlarged and mask low muscle 
mass if only whole body lean tissue was assessed (28). DXA is also a very precise modality for 
assessing body composition. If care is taken to ensure optimal preparation before the scan (fasting, 
refrain from intense exercise) and standardization of patient positioning on the table, the coefficient of 
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variation (CV) for lean soft tissue, fat mass and bone mineral content is generally accepted as <2%, 
<1% and 2% respectively (18). 
Despite the high accuracy and precision, DXA does have a number of practical limitations 
with its use. DXA exposes the individual to radiation, which is contra-indicated for a few populations 
(pregnancy), although the dose received is minor (3.5 µSv – less radiation than living a day in 
Toronto, ON) and is generally accepted as a safe level of exposure for both children and adults (29; 
30). Taller or more obese individuals may not fit properly onto the table, and may require two half 
body scans for assessment. One of the bigger issues is agreement of measures between DXA 
manufacturers, software versions and different x-ray production techniques (fan beam, pencil beam, 
narrow-fan beam), as significant differences have been observed while scanning the same individuals 
on different scanners (31). Even with newer generation DXA scanners, there is need for cross-
calibration equations and use of standard calibration phantoms to ensure good agreement across 
scanners and software versions (32). Although DXA scanners are becoming more widely available in 
both research and clinical settings (for bone mineral assessments), these scanners are rarely used for 
body composition purposes outside of a research setting. 
Because of the poor accessibility of DXA scanners in clinical settings for body composition 
analysis, MRI and CT scans have been commonly used in clinical literature for body composition 
analysis; particularly CT scans, as they are routinely performed for clinical diagnosis in many 
populations such as cancer, liver cirrhosis and ICU (33–35). CT and MRI scans use high dose 
radiation or strong magnetic fields, to produce high resolution axial cross-sectional images and 
analyze body composition at the tissue-organ level, quantifying skeletal muscle or adipose tissue 
directly (Figure 3). 
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 Full body CT and MRI scans can be analyzed using specialized software to quantify whole 
body muscle mass and adipose tissues. The cross-sectional area (CSA) of muscle or adipose tissue is 
analyzed for each scan, combined with the thickness of the scan, a volume can be estimated; which 
has very strong associations with kilogram measures of muscle and adipose tissue from cadaver 
dissections (36). However, full body CT or MRI scans for diagnostic purposes are not performed as 
frequently as regional scans of the body, which often include the abdominal region. Taking advantage 
of this fact,  Shen et al. (2004) examined the agreement between skeletal muscle and adipose tissue 
CSA from a single MRI scan at various anatomical landmarks in the abdominal region and whole 
body muscle and adipose mass from full body MRI scans, observing the strongest associations using 
scans from around the 3rd lumbar vertebra (37). A single scan of the 3rd lumbar vertebra is now a 
commonly used landmark for skeletal muscle and adipose tissue analysis in many clinical 
Figure 3. Pre and post CSA analysis of axial CT scans of the 3rd lumbar vertebra for skeletal muscle and adipose tissue depots.  
Red – muscle CSA (Hounsfield units of -29 to +150), yellow – visceral adipose CSA (Hounsfield units of -150 to -50), green – 
intramuscular adipose CSA (Hounsfield units of -190 to -30), subcutaneous adipose CSA (Hounsfield units of -190 to -30). 
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populations, including cancer (38), liver cirrhosis (34) and ICU (3; 6; 39) populations. Using these 
technologies and expedient modes of analysis, literature investigating the associations between low 
muscularity and clinical outcomes has become more widely accessible and investigated. 
Single slice CT or MRI scans have very precise analysis using specialized software, and have 
CV of 2% for muscle CSA in many clinical populations (3; 40). Although more clinically accessible 
than DXA in many populations, CT and MRI scan analyses still have many limitations (further 
discussed below in section 2.4). Analyzing the scans is time-consuming and requires specialized 
software, which may not be accessible in clinical settings. Moreover, CT and MRI scans are not 
routinely performed for body composition purposes, limiting investigations to retrospective analysis 
(33). 
2.3 Established body composition modalities to identify individuals with lower 
than normal muscularity 
DXA, CT and MRI scans are often used to identify individuals with lower than muscle mass. 
These modalities have cut-points specific to their analysis and have been applied in many clinical 
populations (4; 6; 34; 39; 41; 42). Baumgartner el al. (1998) developed sex-specific low lean tissue 
cut-points and applied those cut-points in a large (n=883) cohort of elderly Hispanic and non-
Hispanic white males and females using DXA appendicular lean tissue mass normalized to their 
height squared (4). In that study, lower than normal lean tissue was statistically defined as being less 
than two standard deviations below a healthy young reference group and these cut-points were 
significantly associated with self-reported physical disability, independent of age, obesity, ethnicity 
and health behaviors in the elderly adult cohort (4). These same cut-points have also been applied in 
lung and colorectal cancer populations using DXA scans, which were then transferred to CT analysis 
using the 3rd lumbar vertebra landmark in those same patients (38). Subsequently, many studies have 
utilized those CT cut-points in many cancer, liver cirrhotic and ICU populations, finding a number of 
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associations between low muscle mass and poor clinical outcomes (11; 13; 28; 35). ICU specific cut-
points using CT analysis have also been developed by performing a receiver operator characteristics 
(ROC) curve and observing higher rates of mortality in those with low muscle CSA (<110 cm2 for 
females and <170 cm2 for males) (39). The growing evidence supporting the significance of muscle 
mass or lean tissue on clinical outcomes highlights the need to further investigate the implications of 
interventions aimed at improving lean tissue and to determine if meaningful clinical or functional 
outcomes are improved. 
2.4 Limitations and challenges with CT, MRI and DXA 
Although DXA, CT and MRI are highly sought after due to their accuracy and precision in 
quantifying lean tissue or muscle mass, there are a number of practical limitations associated with 
their use, such as cost, availability of these scanners in clinical settings for body composition analysis, 
body size limits to fit within the scanner and in some cases, radiation exposure (5). These issues taken 
together, constrain the wide spread application of these comprehensive body composition techniques 
in many clinical settings. This often limits clinical investigations to anthropometric measures, such as 
weight and height; which are unable to quantify specific tissues, leading to variable and inaccurate 
measures of muscle. Even investigations utilizing CT or MRI analysis for body composition measures 
are generally limited to retrospective analysis, given that prospective analysis would be expensive, 
potentially burdensome in terms of time-commitment and, in the case of CT, would expose the patient 
to additional radiation. It would therefore be advantageous to use a modality that can circumvent 
many of these limitations and prospectively assess lean tissue or muscle mass in clinical 
investigations. Ultrasound may elude many of these limitations and has the ability to prospectively 
estimate lean tissue or muscle mass (1), while being portable, noninvasive, easy to use and readily 
available in most clinical settings (43).  
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2.5 Assessing lean tissue quantity: the role of ultrasound 
2.5.1 An overview of ultrasound 
Ultrasound devices generate high frequency sound waves (1-14 MHz) through an electrically 
stimulated piezoelectric crystal in the head of the transducer. When an alternating current is applied to 
the piezoelectric crystal, high frequency vibrations occur, producing ultrasonic waves. In conjunction 
with acoustic coupling gel, these ultrasound waves propagate through the skin and are then partly 
reflected and partly transmitted through the underlying subcutaneous tissues (44). The amount of 
reflection and transmittance that occurs is dependent upon changes in acoustic impedance and is 
determined by the characteristics of the underlying tissues; these reflections and transmissions occur 
at transitional interfaces between two different tissues (i.e. adipose-muscle interface) (44). The waves 
that are reflected back to the transducer are received by the piezoelectric crystals, processed based on 
timing, frequency and amplitude of the reflected waves, finally being displayed as a 2-dimensional 
image on the ultrasound screen. However, since the ultrasound waves are travelling through multiple 
different tissues (skin, adipose tissue, muscle), and the tissue properties change the velocity of the 
ultrasound waves, there is an assumption with ultrasound imaging that the wave propagates at 
approximately 1540 m/s across soft tissues (45). In reality, the ultrasound wave propagates at 
approximately 1450 m/s in adipose tissue and 1580 m/s in muscle, and may therefore overestimate 
adipose tissue thickness and underestimate muscle thickness (45). However, cadaver dissection has 
demonstrated strong agreement with ultrasound measured thickness, suggesting the velocity 
assumption is most likely a negligible issue (46). 
2.5.2 Using ultrasound to assess muscle mass 
Ultrasound can be used for muscle mass estimations by obtaining transverse cross-sectional 
images of predefined landmarks and then analyzing those images for the thickness or CSA of the 
underlying muscle groups (Figure 4). These thickness or CSA measures, in conjunction with 
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prediction equations, can give estimates of whole body or regional measures of lean tissue or muscle 
mass (47–51). While muscle CSA may provide a more comprehensive analysis of muscle architecture 
compared to thickness, thickness is more commonly utilized for lean tissue mass estimations because 
analysis is less time-consuming, it is easier to delineate the muscle-bone interface compared to the 
entire fascia of the muscle and many muscle groups, such as the vastus lateralis, have CSA that may 
be too large to visualize in a single image using linear ultrasound probes. 
2.5.3 Existing protocols for measuring muscle thickness with ultrasound and 
estimating fat-free, lean tissue or muscle mass 
To date, many ultrasound protocols have been developed to measure either muscle thickness 
or CSA of a wide range of muscles using a variety of different landmarks. Some of these protocols 
include measuring muscle thicknesses for: 9 anterior and posterior sites (47–49; 52–54), 7 anterior 
and posterior sites (50; 55), 2 site bilateral of the quadriceps (2; 56–58), 4 anterior and posterior sites 
Figure 4. Transverse cross-sectional ultrasound image of the quadriceps muscle 
layer thickness. Rectus femoris CSA – 6.55 cm2; muscle thickness – 4.59 cm. 
  13 
on the lower limbs (59), 3 anterior sites on upper and lower limbs (60) and for measuring CSA of the: 
rectus femoris (12; 61; 62) and vastus lateralis (63; 64). However, only the 9 site protocol has been 
more extensively validated for lean tissue or muscle mass estimations (Table 1) (65). 
 The 9-site protocol has been compared to hydrostatic weighing (48), MRI (49; 52; 66) and 
DXA (47; 59; 65) measures of fat-free, lean tissue or muscle mass and has regression coefficients that 
range from 0.75 to 0.99 (Table 1). These regression coefficients have been observed in both males 
and females, younger (<60 years of age) and older (>60 years of age) adults and between different 
ethnicities (Japanese and Caucasian). These studies comparing the accuracy of the 9-site protocol 
have also performed Bland-Altman plot analysis (67) and the largest observed limits of agreement 
were ±4 kg when compared with either DXA lean tissue mass or MRI muscle mass. Importantly, 
there were no observable biases in the cross-validation groups within any given study.  Taken 
together, there is strong agreement between the 9-site ultrasound protocol and DXA or MRI measures 
of lean tissue or muscle mass. However, while studies developing regression equations did not 
observe any bias, Abe et al. (2014) externally assessed the accuracy of four previously published 
regression equations using the 9-site protocol. These regression equations, which were originally 
developed in Japanese populations, were applied in 77 middle aged and older Caucasian adults (aged 
50-78) and significant systematic or proportional bias was observed in three of the four regression 
equations tested, with only one equation having no bias and acceptable limits of agreement (65). 
Overall, ultrasound may have a high degree of accuracy for estimating lean tissue or muscle mass 
using the 9-site protocol, but regression equations may be population specific.  
While the 9-site protocol may be accurate, it is not be feasible in many clinical settings 
because it requires the inclusion of posterior measures in patients who are typically in supine position, 
sedated/unconscious and/or difficult to move. Not to mention, that a standing protocol may result in  
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some variability depending on the amount of time the participant is standing, which may alter fluid 
distribution (68). This is especially important since validation studies often use DXA, where 
participants are supine, as the reference method. Therefore, viable bedside protocols have been 
developed to assess and track changes in muscle thickness and their relation to functional and clinical 
outcomes (2; 12; 62; 69), but they have yet to be extensively tested for accuracy in predicting lean 
tissue mass. To date, two studies have compared viable bedside protocols against measures of lean 
tissue mass. Campbell et al. (1995) developed an ultrasound protocol that measures the muscle 
thicknesses of the anterior upper arm, anterior forearm and anterior upper leg in a supine position and 
observed in 36 healthy volunteers that these summed muscle thicknesses were strongly associated 
(r=0.87) with DXA measured lean tissue mass. More recently, Berger et al. (2015) compared rectus 
femoris muscle thickness, albeit in a seated position with the knee bent, to DXA measured 
appendicular and whole body lean tissue in a group of 105 younger and older adults, observing 
moderate associations (r=0.74). Although the latter of the two studies is not directly applicable to 
bedside implementation, these two studies demonstrate that readily accessible supine landmarks can 
produce fairly strong associations with lean tissue mass and that they may be useful surrogates of 
muscle mass at the bedside. 
2.5.4 Identifying lower than normal lean tissue or muscle mass with ultrasound 
Given the potential for ultrasound to prospectively assess muscle mass in clinical settings, it 
is valuable to examine whether ultrasound has the capacity to accurately identify individuals with 
lower than normal muscle mass. Recently, a number of studies have assessed the ability of ultrasound 
to discriminate between normal and low levels of lean tissue or muscle mass, using a variety of 
different protocols and previously established cut-points from DXA, BIA, MRI and CT measures of 
lean tissue or muscle mass (3; 41; 54; 70–72). Ismail et al. (2015) investigated the ability of a 5-site 
ultrasound protocol (in seated position) to distinguish between 10 normal and 10 lower than normal 
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lean tissue mass women, identified using previously published DXA cut-points. Significant 
differences in the summed muscle thicknesses were observed between the normal and low lean tissue 
groups, indicating these anterior and posterior sites (trapezius, brachioradialis, deltoid, pectorals and 
rectus femoris) may be useful markers of low lean tissue. However, in addition to the small sample 
size, no further specificity or sensitivity analysis was performed, making it difficult to draw 
conclusions on whether this ultrasound protocol can accurately discriminate low from normal lean 
tissue on an individual basis. Minetto et al. (2015) established muscle specific cut-points for the 
rectus femoris and vastus lateralis thickness using ultrasound in a group of 60 young participants (20-
36 years of age) by taking 2 standard deviations below the mean thickness, after which they applied 
those cut-points and previously established BIA cut-points in a group of 44 older adults (67-93 years 
of age). Using rectus femoris and vastus lateralis cut-points, 86% of the older adults were identified 
as having lower than normal muscle thickness, whereas BIA identified between 2% and 75% of 
individuals as having lower than normal fat-free mass, depending on which BIA specific cut-points 
were used. This large discrepancy in the classification of low fat-free mass using BIA makes 
interpretation of these ultrasound cut-points challenging. Since there is no definitive identification of 
individuals with lower than normal fat-free mass, we cannot adequately assess utility of the 
ultrasound cut-points in identifying these individuals. However, these results are interesting, as they 
demonstrate that site specific (i.e. quadriceps) low muscle mass may be an important aspect to 
investigate. This is further supported by literature indicating a greater loss of lower limb musculature 
relative to upper limb musculature in aged individuals (73). Furthermore, there is evidence of 
preferential atrophy of the quadriceps musculature compared to the hamstrings musculature in older 
adults (74–76), suggesting that it may be advantageous to use a modality that can assess site specific 
muscle atrophy (ultrasound), compared to modalities that measure whole body or even lower limb 
lean tissue mass (DXA). Abe et al. (2015), used the previously developed 9-site ultrasound protocol 
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to predict DXA appendicular lean tissue mass and compared the agreement in identifying individuals 
with low lean tissue categorized by DXA cut-points. Although a small proportion of their participants 
had low lean tissue mass, they described that 6 of 7 participants were correctly identified as low lean 
tissue mass using ultrasound. Kuyumcu et al. (2016) used ultrasound assessment of the gastrocnemius 
muscle groups to identify sarcopenic individuals (low fat-free mass index from BIA and low handgrip 
strength) in a group of 100 older adults. Of the 100 individuals, 8 males and 6 females were identified 
as being sarcopenic, and a ROC analysis, using gastrocnemius thickness or fascicle length, resulted in 
an area under the curve (AUC) between 0.78 and 0.83. However, sex was not accounted for during 
ROC analysis, making these results difficult to interpret, since a lower than normal muscle thickness 
for females, should be lower than males. Conservatively, considering these data, in community 
dwelling older adults, the ability of ultrasound to identify low muscle is moderate (based on the ROC 
analysis from Kuyumcu et al. (2016)). However, with the wide range of ultrasound protocols applied, 
reference techniques used and statistical analyses performed, there is still much work required to 
ensure an optimal and consistent approach for identifying low muscle with the use of 
ultrasonography.  
Recently, in clinical populations, ultrasound has also been used to identify lower than normal 
muscle mass in ICU and liver cirrhotic patients. Within the ICU population, the 4-site protocol, using 
maximal compression of the ultrasound probe against the skin, has been applied and compared to 
abdominal CT analysis for identification of low muscle in 145 mixed medical and surgical patients 
near ICU admission (3). A ROC analysis revealed an AUC of 0.67 for ultrasound thickness alone, 
which improved to 0.77 with the addition of covariates age, sex and body mass index (BMI). In liver 
cirrhotic patients, the same 4-site protocol was applied, but using both minimal and maximal 
compression of the ultrasound probe against the skin, and was compared to CT and MRI analysis in 
159 patients. Minimal compression resulted in better associations with low muscle mass and in 
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conjunction with BMI, developed an AUC of 0.78 for males and 0.89 for females using a ROC 
analysis. Although few studies to date have used ultrasound to identify low muscle in clinical 
populations, the results thus far demonstrate that ultrasound has moderate to strong capabilities to 
identify lower than normal muscle mass, similar to community dwelling older adults.  
2.5.5 Limitations of ultrasound measures of muscle thickness 
While ultrasound has potential to assess muscle mass, there are a number of limitations 
associated with its use such as error in identification of bony landmarks, consistency in the placement 
of the probe (centered on landmark, force applied against the skin and tilt of the probe), accurate and 
consistent caliper placement for thickness assessment and the need for prediction equations for lean 
tissue mass. Examiners using different levels of force on the ultrasound probe can induce varying 
levels of tissue depression, creating potential deviations in muscle thickness measures (77), making it 
difficult to directly compare studies using different approaches. These deviations may also result in 
high variability, as muscle thickness measures are relatively small in magnitude (generally less than 5 
cm for larger muscle groups) and small differences between examiners may result in relatively large 
CV, especially in individuals who may already have lower than normal muscle thicknesses. In 
addition, when analyzing the image, placement of the electronic calipers may vary between 
examiners; specifically, determining the muscle border can be confounding due to the multiple fascial 
layers surrounding the muscle (epimysium vs perimysium) and infiltration of adipose tissue into the 
muscle results in increased attenuation of the ultrasound wave, producing a poorer quality image.  
However if care is taken to ensure correct identification of landmarks, neutral probe tilt, 
minimal depression of the subcutaneous tissues and correct identification of the muscle fascia, 
ultrasound literature has demonstrated good to excellent reproducibility both within and between 
examiners (56). For measures of peripheral muscle thickness, intra-rater reliability has produced CV 
values between 2.3 to 3.0 % (2; 78–80) and intra class correlation coefficients (ICC) between 0.71 to 
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0.99 (56; 57; 68). Fewer studies have investigated inter-rater reliability for muscle thickness, but, 
those that have, obtained ICC values between 0.73 to 0.99 (56; 81). While it may seem that 
ultrasound is rather reliable in assessing muscle thickness (82), both within and between raters, a 
major limitation associated with most literature that examines the reliability of ultrasound for 
thickness measures is, that more often than not, these investigations focus on using previously defined 
landmarks, for both intra-rater and inter-rater reliability. That is to say, the entire ultrasound protocol, 
from landmarking to image acquisition to caliper placement is not being investigated; most studies, 
assess the latter two aspects. To date, only a single investigation has employed methodology to assess 
the reliability of the entire ultrasound protocol (83). Using the 9-site protocol in acute stroke patients, 
investigators observed strong reliability (ICC >0.80) in many, but not all landmarks. Of these 
landmarks, one of the more reliable sites was the anterior thigh (ICC >0.9), but the bony landmarks 
used in the 9-site protocol for anterior thigh thickness are different than those used in the 4-site 
protocol (83). Although promising, the robustness of these measures need to be further explored, in 
healthy, obese and clinical populations, to ensure specific challenges associated with those 
populations (i.e. identification of bony landmarks in obese individuals) do not confound the reliability 
of muscle thickness measures. 
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Chapter 3 
Rationale, Objectives and Hypotheses 
3.1 Rationale 
Despite the potential utility of ultrasound in not only quantifying muscle mass, but also 
identifying those individuals with lower than normal muscle mass in a clinical setting, research 
investigating the accuracy of viable bedside protocols is lacking. The majority of research has focused 
on protocols (such as the 9-site protocol) that lack the feasibility of being conducted in most clinical 
settings. Viable bedside protocols (such as the 4-site protocol) have been employed and have be 
shown to be feasible in both healthy (56), liver cirrhotic (41) and ICU populations (2; 3), but they 
have yet to be comprehensively evaluated for accuracy against whole body measures of lean tissue or 
muscle mass. Although two studies have compared the agreement of viable bedside ultrasound 
protocols to accurate measures of lean tissue in healthy participants (58; 60), recent literature has 
highlighted potential improvements to ultrasound methodology that was not previously utilized in 
those studies, such as accounting for limb length or height to improve accuracy (84). Furthermore, a 
recent multicentre study in the ICU investigated the associations between the 4-site ultrasound 
protocol and 3rd lumbar vertebra muscle CSA from CT scans, which albeit is a non-whole body 
measure of muscle mass, but observed significant improvements when physical covariates such as 
age, sex and BMI were accounted for. Viable bedside protocols need to be evaluated for accuracy 
against an well-established measures of lean tissue or muscle mass in a heterogeneous participant 
cohort, accounting for physical characteristics, to assess the utility of these measures in a population 
that is not confounded by clinical factors, such as edema, before applying these protocols in future 
clinical investigations. 
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Multiple stages of evaluation (Figure 5) are needed before these protocols are applicable and 
meaningful in a clinical setting. First, the protocol needs to be compared with a previously 
established, precise and accurate body composition modality (such as DXA) in healthy individuals to 
ensure that it is a valid approach in estimating lean tissue or muscle mass. Second, the accuracy of the 
previously developed models need to be internally or externally validated, to ensure the 
generalizability of the model. Third, the intra-rater and inter-rater reliability of the entire ultrasound 
protocol needs to be assessed, in multiple different populations (young, old, obese), to ensure that 
these measures can be confidently obtained across multiple clinical centres. Fourth, the associations 
between ultrasound measures of muscle mass and measures of strength and physical function need to 
be elucidated to ensure these measures are valid at identifying individuals who may be sarcopenic, as 
current guidelines on the definition of sarcopenia include both low muscle mass and poor physical 
function or strength (26). Fifth, the sensitivity of ultrasound based muscle thickness measures need to 
be assessed to determine how well they track changes in muscle mass over time. Lastly, all of these 
steps will need to be re-evaluated in specific clinical populations, to ensure the validity within those 
populations. This thesis primarily focused on steps one and two, with secondary objectives assessing 
step three. This work creates a foundation upon which viable bedside protocols can be optimized for 
accuracy and reliability, prior to application in clinical populations.  
 A potentially confounding factor for measures of muscle thickness in clinical populations is 
the presence of edema. Edema is the abnormal accumulation of interstitial fluid and is thought to 
Figure 5. Multiple stages of evaluation for a clinically accessible body composition modality 
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artificially increase measures of muscle thickness (56). Edema should be considered before 
developing ultrasound guidelines for use in a clinical setting. Although maximal compression of the 
ultrasound probe against the skin has been suggested as a potential strategy to account for edema (56), 
there has only been a single investigation comparing maximal and minimal compression, determining 
that minimal compression was superior, but this was performed in liver cirrhotic patients and 
compared to a non-whole body measure of muscle mass (41). Before being further applied in a 
clinical setting, maximal compression and minimal compression should be compared in a healthy 
population to determine which of these approaches better estimates lean tissue mass.  
The 4-site ultrasound protocol has been used in clinical populations that are less mobile, and 
may be a versatile method for quantifying muscle thickness. Thus, I assessed the agreement between 
4-site protocol (using minimal and maximal compression), performed in a supine position, and DXA 
appendicular lean tissue mass. Additional anatomical landmarks from the 9-site protocol, obtained in 
a supine position, and easily obtained covariates (sex, age, and BMI) were used to optimize the 
existing 4-site protocol, to develop a protocol that more accurately predicts lean tissue, but is still 
applicable at the bedside. Lastly, previously published low lean tissue mass DXA cut-points were 
used to categorize participants and the ability of the optimized ultrasound protocol to identify these 
individuals was assessed.  
3.2 Objectives 
3.2.1 Primary objectives 
In a cohort of participants that have a wide range of low to high lean tissue mass (approximately 30 – 
80 kg of lean tissue mass), we proposed:  
1. To evaluate the agreement between muscle thickness measured by ultrasound using the 4-site 
protocol and regional and appendicular measures of lean tissue mass derived from DXA 
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2. To improve the accuracy of the 4-site protocol for predicting appendicular lean tissue mass 
by incorporating easily obtained covariates and additional bedside accessible muscle 
thicknesses from the 9-site protocol 
3. To assess the ability of the optimized ultrasound protocol (objective #2) to discriminate 
between individuals with normal and low lean tissue mass using established cut-points for 
appendicular lean tissue mass index derived by DXA.  
3.2.2 Secondary objectives 
1. To compare the accuracy of using minimal and maximal compression of the ultrasound probe 
in measuring muscle thickness to assess lean tissue mass 
2. To obtain additional accessible muscle thicknesses from the 9-site protocol and to compare 
the accuracy of the 9-site protocol to the 4-site and optimized ultrasound protocols for 
appendicular lean tissue mass predictions. 
3. To evaluate the intra-rater reliability of the image acquisition and caliper placement of the 4-
site protocol and inter-rater reliability of the entire 4-site protocol  
3.3 Hypotheses 
3.3.1 Primary hypotheses 
1. There will be a strong (r > 0.8) linear association between the 4-site ultrasound muscle 
thicknesses and DXA-derived regional and appendicular lean tissue mass. 
2. Anterior muscle thicknesses of the upper limbs (anterior upper arm and anterior forearm) and 
covariates sex, age and BMI will significantly improve predictive accuracy of DXA derived 
appendicular lean tissue mass. 
3. There will be a strong (AUC ≥0.85) ability to identify individuals with low lean tissue mass 
using the optimized ultrasound protocol. 
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3.3.2 Secondary hypotheses 
1. Minimal compression will produce a stronger association between ultrasound muscle 
thickness and DXA lean tissue than maximal compression 
2. There will be a strong (r > 0.9) linear association between 9-site muscle thickness protocol 
and DXA-derived appendicular lean tissue mass. Further comparison with the 4-site and 
optimized protocols will demonstrate that the 9-site protocol is more accurate in predicting 
appendicular lean tissue mass. 
3. There will be a strong (ICC>0.80, CV<5%) degree of intra-rater and inter-rater reliability for 
the 4-site protocol. 
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Chapter 4 
Methodology 
4.1 Study design 
This observational thesis recruited 96 participants to attend a single data collection session. 
Participants underwent anthropometric measures, a whole body DXA scan and ultrasound 
assessments using the 9-site and 4-site protocols in supine and prone positions. A small subset (n=16) 
of participants had inter-rater reliability performed using the 4-site protocol for a single leg 
(alternating between dominant and non-dominant legs). This study was reviewed and cleared by a 
University of Waterloo Clinical Research Ethics Committee. Written informed consent was obtained 
from all participants in accordance with established protocols for human research. 
4.2 Participants 
Participants (≥18 years of age) were recruited from the University of Waterloo student 
population, from the Kitchener-Waterloo community and from the Waterloo Research Aging 
Participant Pool. Participants were screened using a health questionnaire and excluded if they: 1) had 
a previous history of neuromuscular disorders, 2) were currently or suspect they may be pregnant, 3) 
had undergone a barium swallow or nuclear medicine scan within the past three weeks, 4) had a 
stroke within the past five years, and 5) had a prosthetic joint replacement. These exclusion criteria 
were in place to avoid factors that would have confounded DXA measured lean tissue, ultrasound 
measured muscle thickness or the comparison between them. To obtain a heterogeneous cohort of 
participants with a wide range of lean soft tissue mass and to increase the generalizability of these 
results, we attempted to recruit a minimum of 20 participants in each of the following BMI (weight 
(kg)/height2 (m2)) categories: <25 kg/m2, 25 - 30 kg/m2 and >30 kg/m2, but were only successful for 
the <25 kg/m2 and 25-30 kg/m2 groups (only 14 participants were recruited into the >30 kg/m2 
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group). Participants were instructed to refrain from alcohol consumption for 24 hours and moderate to 
vigorous physical activity for 48 hours prior to their scheduled data collection session.  
4.3 Anthropometric data 
Height and weight was obtained with participants in lightweight clothing (loose shorts and t-
shirt) or a cloth hospital gown in their socks or bare feet. Weight was obtained using a balance beam 
scale (Mechanical Beam Scale, Health o meter, McCook, IL) while the participant stood still, with 
both feet on the weighing platform, measured to the nearest 0.1 kg. Height was obtained using a 
standing stadiometer with participant’s heels against the wall and feet as close together as the 
participant was able to maintain, height was measured to the nearest 0.01 m. Circumferences of the 
upper thigh were taken using a flexible tape measure, to the nearest 0.5 cm, at the midpoint and lower 
third between the anterior superior iliac spine and the upper pole of the patella for both left and right 
legs. All anthropometric measures were taken once. 
4.4 DXA scan 
Certified Medical Radiation Therapists conducted one to two whole body DXA scans 
(Hologic Discovery QDR 4500, Hologic, Toronto, ON) on each participant. The second scan was 
required if the participant did not fit within the limits of the scanning table. If two scans were 
required, the scan containing the upper limb within the table limits was used for lean tissue, fat mass 
and bone mineral content for that limb, whereas all other body segments (head, trunk and lower 
limbs) were averaged across both scans. Using Hologic software (version 13.2), the whole body scan 
was segmented into the head, trunk, left and right upper limbs and left and right lower limbs by a 
single investigator according to a standardized protocol (25). The lean tissue of the upper and lower 
limbs (appendicular lean tissue mass) was summed and used as the criterion outcome for all linear 
regression analysis. Appendicular was chosen over whole body lean mass as the reference criteria 
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since DXA cannot distinguish skeletal muscle from other muscle and organ compartments within 
whole body lean tissue measures. This is important to distinguish since whole body lean tissue 
measures may confound the association with ultrasound measured skeletal muscle thickness. Lastly 
and most importantly, the appendicular lean tissue depot is the criteria used to determine if an 
individual has lower than normal lean tissue mass (26); therefore utilizing appendicular lean tissue 
mass as our criterion measure, we were able to determine which muscle thicknesses and covariates 
are most useful for identification of individuals with low lean tissue mass. Individuals were identified 
as have lower than normal lean tissue mass by dividing their appendicular lean tissue mass by their 
height squared (kg/m2) and using previously published cut-points of ≤ 7.26 kg/m2 for males and ≤ 
5.45 kg/m2 for females (4). 
 Regional measures were performed for direct comparison of the 4-site protocol muscle 
thicknesses to the corresponding site on the DXA scan for lean tissue measures (Figure 6). Lean 
Figure 6. Regional assessment using DXA software for site to site comparison of muscle thickness and lean 
tissue mass. 
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tissue at the midpoint and lower third between the anterior superior iliac spine and upper patella was 
measured using the DXA software. The pixels in the y-axis pertaining to the anterior superior iliac 
spine and the upper patella was determined visually and used to calculate the relative distances and 
pixels associated with the midpoint and lower third sites. Subsequently, rectangular boxes, 2 pixels in 
height and wide enough to encompass the skin on both sides of the upper thigh, were placed to 
quantify the lean soft tissue. Lean tissue was averaged across all 4 sites and compared to average 
muscle thickness from the 4-site protocol using both minimal and maximal compression. A height of 
2 pixels was chosen as this is the smallest height a region of interest box can be made, and is 
equivalent to approximately 2.6 cm, in comparison to a 1 cm wide ultrasound probe imaging size. 
4.5 Ultrasound protocols 
A real-time B-mode ultrasound imaging device (M-Turbo, SonoSite, Markham, ON) 
equipped with a multi-frequency linear array transducer (5-10 MHz) was used to obtain transverse 
images of muscle groups at predefined sites. Adjustable parameters: gain, time gain compensation 
and compression (dynamic range - neutral) were held constant throughout the imaging process, 
whereas depth was adjusted as required in order to obtain a complete image of the muscle thickness. 
Muscle thickness measures were obtained from frozen images using onscreen calipers, measuring the 
distance between the upper margin of the underlying bone and the lower boundary of the ventral 
fascia of the muscle group of interest (85). For example, the quadriceps muscle thickness 
measurement was the distance between the upper margin of the femoral bone and the lower boundary 
of the ventral fascia of the rectus femoris (8), incorporating both the rectus femoris and the vastus 
intermedialis (Figure 4, page 12). For muscle thickness measures that do not use a bony surface, the 
lower and upper boundaries of the muscle fascia was used for analysis. All measurements were made 
with the participant in the prone or supine position with their ankles wrapped with an adjustable strap 
to ensure neutral rotation of the lower limbs. All bony landmarks were identified by palpation and 
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specific sites to be imaged identified with the use of a flexible tape measure and marked using easily 
removable ink. During image analysis and caliper placement, all raters were blinded to thickness 
measures by the use of a removable sticker on the ultrasound screen to ensure subsequent thickness 
measures were not influenced by prior image analysis. 
Ultrasound images were obtained using two protocols, the 4-site and the 9-site protocol. The 
4-site protocol imaged the anterior surface of the left and right rectus femoris and vastus intermedialis 
muscles from i) the mid-point between the anterior superior iliac spine and the upper pole of the 
patella and ii) the border of the lower third and upper two-thirds between the anterior superior iliac 
spine and the upper pole of the patella (56). The 4-site protocol had two phases, minimal and maximal 
Figure 7. Comparison between minimal (A) and maximal compression (B) protocols within a single participant. 1 – Region 
highlighting ample acoustic coupling gel to ensure no contact occurs between skin and ultrasound probe. 2 – Highlighting 
convex nature of the skin and muscle belly, required for minimal compression. 3 – Skin and muscle belly loose convex shape 
during maximal compression. 
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compression, and each landmark was imaged twice, using each level of compression. Minimal 
compression was achieved by coating the transducer with ample water-soluble transmission gel and 
positioned to obtain an image containing the highest density of cortical bone of the femur (neutral 
probe tilt). A thick layer of ultrasound gel was maintained between the probe-skin interface to ensure 
there is no tissue depression and the operator ensured the muscle belly and skin maintained its convex 
shape prior to freezing the image (Figure 7A). In contrast, maximal compression was considered to be 
maximal attainable compression of the underlying tissue with the transducer (Figure 7B).  
The 9-site protocol was performed only on the right side of the body and each landmark was 
imaged a single time, as previously described by Takai et al. (2014).  The upper arm muscle thickness 
measures were taken on the anterior and posterior surface, 60% distal from the acromial process of 
the scapula to the lateral epicondyle of the humerus. Forearm muscle thickness was taken from the 
anterior surface 30% distal from the radial head to the styloid process of the radius. Abdominal 
measures of muscle thickness were taken 3 cm from the right of the umbilicus. Subscapular muscle 
thickness measures were taken 5 cm directly below the inferior angle of the scapula. Measures of 
thigh muscle thickness were taken on the anterior and posterior surfaces midway between the lateral 
condyle of the femur and the greater trochanter. Finally, the lower leg muscle thickness measures 
were taken on the anterior and posterior surface, 30% distal from the head of the fibula to the lateral 
malleolus. Only minimal compression as described above was used for the 9-site protocol. 
Previous literature has shown improved accuracy in predicting lean tissue when accounting 
for body size differences by multiplying the muscle thicknesses by the corresponding limb length or 
height. Miyatani et al. (2004) compared muscle thicknesses of the upper and lower limbs with their 
corresponding muscle volumes from MRI and demonstrated that multiplying the muscle thickness by 
limb length significantly improved the accuracy in predicting muscle volume. This is further enforced 
by So et al. (2004), who showed that MRI volume of the quadriceps demonstrates a strong association 
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with whole body muscle mass. To obtain a surrogate measure of muscle volume, which was used to 
predict appendicular lean tissue mass, all muscle thicknesses were either multiplied by their 
corresponding limb length or height. 
4.6 Reliability of the 4-site protocol 
 Inter-rater reliability was performed for the 4-site protocol by a second rater, experienced 
with the application of musculoskeletal ultrasound, but who had minimal training applying the 4-site 
protocol. The order of inter-rater reliability measures by the two raters was random, but not 
randomized. Reliability was assessed on a single leg for each participant and alternated between 
dominant and non-dominant legs, in a sequential order. Inter-rater reliability assessment occurred 
according to the following steps: 1) landmarking with ink by rater one, 2) acquisition of image and 
placement of calipers for muscle thickness measures for both minimal and maximal compression 
protocols, with removal and repositioning of the probe between images, by rater one, 3) removal of 
ink landmarks using 70% ethanol wipes by rater 1, and 4) rater 2 performs steps 1-3, blinded to all 
measures from rater 1. Therefore, the second rater was conducting the entire 4-site protocol, on a 
single leg, alternating between dominant and non-dominant legs for each participant. Inter-rater 
reliability was performed on the last 16 individuals participating (31% female), with median 
(interquartile range (IQR)) age, BMI and body fat of 70.5 (67.3-78), 26.4 (22.9-29.9) and 31.3 (26.3-
36.7), respectively. Assessing reliability on the last 16 individuals may have displayed the ideal 
situation for intra-rater reliability, as the primary rater will have gained considerable experience in 
applying the 4-site protocol; but, this would not be the case for inter-rater reliability, as the second 
rater was inexperienced with the 4-site protocol at the start of these 16 individuals. Intra-rater 
reliability was assessed by comparing the 1st measure to the 2nd measure for all 4-site landmarks, 
according to steps 1 and 2, as described above. 
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4.7 Sample size 
Utilizing online software developed by Dr. David Schoenfeld (Professor in Department of 
Biostatistics at Harvard T.H. Chan School of Public Health and Professor of Medicine, Harvard 
Medical School) for sample size calculations, a two tailed test (α=0.05) was performed using standard 
deviations of 374 cm3 (84) and 0.9 cm (47) for knee extensor muscle volume measured using MRI 
and muscle thickness measured using ultrasound. A sample size of 97 was calculated, based on 
setting the power at 80%, with a minimal detectable difference of 120 cm3. The minimal detectable 
difference was calculated using a regression equation to predict knee extensor volume (84), using a 
minimal change in muscle thickness of 0.3 cm.  
4.8 Statistical analysis 
4.8.1 General analysis 
Normality was assessed for continuous variables using the Shapiro-Wilks test. Normality was 
violated for numerous variables and therefore, descriptive statistics are reported as median and IQR 
(Q1-Q3) and differences between males and females or young and older adults was analyzed using 
the Mann-Whitney U test. Differences in proportion of low lean tissue was assessed using a Chi-
square test. A Fisher z transformation was utilized to assess if there was a significant difference 
between regression coefficients comparing minimal or maximal compression to site specific measures 
of lean tissue mass. Intra-rater and inter-rater reliability was assessed using CV, ICC and Bland-
Altman plots (described below in section 4.8.4). ICC equation (1,1) was used for both intra-rater and 
inter-rater reliability, as it is considered the most conservative approach (87). All analysis was 
performed using Sigma Plot 13 (Systat Software, San Jose, CA) and the level of significance was set 
at p≤0.05. 
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4.8.2 Cross-validation analysis 
In an attempt to account for overfitting of our models, a 3-fold cross-validation analysis was 
used for all linear and logistic regression and the ROC curve analysis. A 3-fold cross-validation splits 
the participant cohort into 3 equally distributed folds (or groups), where model training 
(development) occurs with 2 of the 3 folds, with subsequent validation in the left out fold; this is 
performed 3 times, utilizing all permutations (Figure 8) (88). All participants were stratified by their 
appendicular lean tissue mass index (kg/m2) and then randomly allocated to folds 1, 2 or 3, to ensure 
equal proportions of lower than normal lean tissue mass individuals in each fold. For linear 
regression, model parameters coefficient of determination (r2) and standard error of the estimate 
(SEE) were averaged across each cross-validation fold to determine average model performance. For 
logistic regression and ROC analysis, model parameters odds ratio and c-index (area under ROC 
curve) were averaged across model development and cross-validation folds as an average of model 
performance.  
Figure 8. Schematic of 3-fold cross-validation for model development and testing 
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4.8.3  Regression and ROC analysis 
The 4-site protocol muscle thicknesses were averaged across all sites, multiplied by limb 
length and was used predict appendicular lean tissue mass using linear regression analysis. The 9-site 
protocol muscle thicknesses were summed, multiplied by height and used to predict appendicular lean 
tissue mass using linear regression analysis. To determine the variables for the optimized protocol, 
backwards stepwise regression, incorporating all 96 participants, was performed using the 4-site 
muscle thicknesses, a-priori defined accessible muscle thicknesses of the anterior upper arm, anterior 
forearm and anterior lower leg from the 9-site protocol and easily obtained covariates age, sex and 
BMI. Multiple linear regression using variables identified in the backwards stepwise regression was 
performed to predict appendicular lean derived from DXA. To assess the ability of the optimized 
protocol to identify low lean tissue mass individuals, we performed a ROC analysis within each fold. 
In order to increase the sample of low lean tissue mass individuals, we combined males and females 
within each fold by developing a multiple logistic regression model to identify low lean tissue mass, 
using variables identified in the backwards stepwise regression. The log odds from logistic regression 
for each cross-validation fold was used as input for the ROC analysis. 
4.8.4 Bland-Altman analysis 
Bland-Altman plots were used to assess the absolute agreement at the individual level for the 
4-site, 9-site and the optimized ultrasound protocol by comparing predicted and DXA measured 
appendicular lean tissue mass and for assessing reliability of the 4-site protocol, as previously 
suggested (87). Bland-Altman analysis examines the spread of the differences between two measures, 
compared against their averages, to determine if the absolute differences between the two measures is 
consider an acceptable level of error (limits of agreement: mean difference ± 1.96 SD) for the new 
technique to be considered an accurate surrogate of the reference technique or to accept the technique 
as reliable (89). While the limits of agreement will contain 95% of the differences for the current 
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participant cohort, if the technique that is being validated is intended to be applied to other 
populations as a surrogate of the reference technique, it has been suggested to state the tolerance 
limits (upper and lower 95% CI for the limits of agreement), as these would contain 95% of future 
predictions for a new participant cohort (90). To ensure the validity of the limits of agreement, a 
regression analysis was performed for the differences against averages to assess for proportional bias 
and homoscedasticity of the differences was assessed visually by examining a plot of the residuals of 
the regression analysis against averages (89; 90). Lastly, a major, but often neglected step of Bland-
Altman analysis (91), is to state whether the limits of agreement are clinically acceptable. 
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Chapter 5 
Results 
5.1 Physical and demographic description of participants 
Ninety-six participants were recruited (86% Caucasian), with a median (IQR) age of 36.5 
(24.0-72.0) years, BMI of 24.3 (22.3-27.3) kg/m2 and body fat of 30.2 (24.3-36.8) % (Table 2). Of the 
96 participants, 57% were female, and compared with males, significant differences were observed 
for BMI (p=0.021) and body fat (p<0.001), but not age (p=0.279). Comparing young and older adults, 
significant differences were observed for age (p<0.001), BMI (p<0.001) and body fat (p<0.001) 
(Table 2). 
Table 2. Physical and demographic description of participant cohort. 
Variable 
Median (IQR) 
All 
(n=96) 
Males 
(n=41) 
Females 
(n=55) 
p-value 
Young 
(<60, n=55) 
Older 
(≥60, n=41) p-value 
Age, years 
36.5  
(24.0-72.0) 
39.0  
(25.0-73.0) 
35.0  
(23.0-69.0) 
0.279 
24.0  
(23.0-30.0) 
73.0  
(69.0-78.0) 
<0.001 
Sex, % female 57% - - - 60% 54% - 
Height, m 
1.69  
(1.62-1.77) 
1.77  
(1.71-1.81) 
1.64  
(1.58-1.69) 
<0.001 
1.70  
(1.64-1.76) 
1.66  
(1.59-1.78) 
0.173 
Weight, kg 
70.5  
(62.8-82.3) 
82.0  
(71.9-88.1) 
65.2  
(58.5-70.9) 
<0.001 
68.0  
(60.3-76.8) 
75.8  
(64.7-84.2) 
0.063 
BMI, kg/m2 
24.3  
(22.3-27.3) 
25.7  
(23.9-27.5) 
23.7  
(21.8-26.5) 
0.021 
23.7  
(21.6-25.7) 
26.6  
(23.7-29.2) 
<0.001 
Underweight 
≤18.5 kg/m2 0 0 0 - 0 0 - 
Normal  
   18.5–24.9 kg/m2 52 16 36 - 38 14 - 
Overweight   
25.0–29.9 kg/m2 30 19 11 - 12 18 - 
Obese  
≥30.0 kg/m2 14 6 8 - 5 9 - 
Body fat, % 
30.2  
(24.3-36.8) 
25.0 
(20.4-29.8) 
34.9 
(29.3-41.0) 
<0.001 
27.3 
(21.7-33.8) 
35.1  
(29.0-41.5) 
<0.001 
Ethnicity - - - - - - - 
     Caucasian, n 83 35 48 - 42 41 - 
     Asian, n 12 5 7 - 12 0 - 
     Other, n 1 1 0 - 1 0 - 
IQR, interquartile range. 
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For all participants, median whole body lean tissue mass, appendicular lean tissue mass and 
appendicular lean tissue mass index was 44.7 (37.6-54.7) kg, 19.2 (15.6-24.2) kg and 6.92 (5.82-7.73) 
kg/m2, respectively (Table 3). In total, 17 of 96 (18%) participants were identified as having lower 
than normal lean tissue (males ≤7.26 kg/m2; females ≤5.45 kg/m2), despite that no participants were 
classified as underweight according BMI. Median appendicular lean tissue was significantly different 
between males and females (p<0.001) and between young and older adults (p=0.041), with no 
differences seen in the proportion of low muscle mass between males and females (p=0.341) or 
between young and older groups (p=0.864) (Table 3). 
Table 3. Descriptive summary of DXA measures of lean tissue 
Variable 
Median (IQR) 
All 
(n=96) 
Males 
(n=41) 
Females 
(n=55) 
p-value 
Young 
(<60, n=55) 
Older 
(≥60, n=41) p-value 
Whole body 
lean soft 
tissue, kg 
44.7 
(37.6-54.7) 
55.4  
(51.3-59.5) 
37.9  
(35.9-42.2) 
<0.001 
44.8  
(37.9-55.5) 
42.6  
(36.1-53.3) 
0.310 
Appendicular 
lean tissue, kg 
19.2  
(15.6-24.2) 
24.7  
(21.7-27.2) 
15.8  
(14.7-17.8) 
<0.001 
19.8  
(16.3-25.3) 
17.5  
(14.7-23.4) 
0.041 
Appendicular 
lean tissue 
index, kg/m2 
6.92  
(5.82-7.73) 
7.75  
(7.38-8.56) 
6.03  
(5.50-6.72) 
<0.001 
7.26  
(6.03-8.07) 
6.60  
(5.52-7.43) 
0.033 
Proportion 
low lean 
tissue, n/N 
and % 
17/96 
18% 
5/41 
12% 
12/55 
22% 
0.341 
6/55 
11% 
11/41 
27% 
0.864 
Site specific 
lean soft 
tissue, kg 
0.40  
(0.34-0.47) 
0.45  
(0.41-0.54) 
0.36  
(0.31-0.40) 
<0.001 
0.45  
(0.37-0.51) 
0.38  
(0.31-0.41) 
<0.001 
IQR, interquartile range. 
Muscle thicknesses were significantly different between males and females for both the 9-site 
(p<0.05) (Table 4) and 4-site ultrasound protocols (p<0.001) (Table 5). Comparing younger and older 
adults, significant differences were observed for all muscle thicknesses using the 4-site protocol 
(p<0.001) (Table 5), but using the 9-site protocol, significant differences were only seen for the 
  41 
muscle thicknesses of the posterior upper arm, abdominal, anterior forearm, anterior upper leg, 
posterior upper leg and combined total (p<0.05), but not for the subscapular, anterior upper arm, 
anterior lower leg and posterior lower leg (p>0.05) (Table 4).  
Table 4. Descriptive summary of ultrasound measured muscle thickness using the 9-site protocol 
Variable 
Median 
(IQR) 
All 
(n=96) 
Males (n=41) 
Females 
(n=55) 
p-value 
Young 
(<60, n=55) 
Older 
(≥60, n=41) p-value 
Anterior 
upper arm, 
cm 
2.76 
(2.31-3.50) 
3.55 
(3.20-3.86) 
2.37 
(2.20-2.70) 
<0.001 
2.99 
(2.34-3.45) 
2.67 
(2.29-3.53) 
0.364 
Posterior 
upper arm, 
cm 
2.32 
(1.75-3.03) 
3.06 
(2.56-3.61) 
1.93 
(1.56-2.31) 
<0.001 
2.51 
(1.98-3.38) 
1.95 
(1.50-2.57) 
<0.001 
Anterior 
forearm, cm 
1.58 
(1.29-1.84) 
1.80 
(1.55-2.06) 
1.36 
(1.16-1.61) 
<0.001 
1.69 
(1.31-1.94) 
1.47 
(1.27-1.70) 
0.046 
Abdominal, 
cm 
1.02 
(0.82-1.34) 
1.16 
(0.84-1.59) 
0.99 
(0.77-1.19) 
0.039 
1.23 
(1.01-1.49) 
0.80 
(0.65-0.95) 
<0.001 
Subscapular, 
cm 
0.81 
(0.63-1.02) 
0.96 
(0.76-1.24) 
0.70 
(0.55-0.92) 
<0.001 
0.83 
(0.64-1.01) 
0.75 
(0.61-1.05) 
0.612 
Anterior 
upper leg, 
cm 
3.34 
(2.57-3.89) 
3.77 
(3.12-4.39) 
2.96 
(2.46-3.52) 
<0.001 
3.77 
(3.12-4.38) 
2.65 
(2.25-3.23) 
<0.001 
Posterior 
upper leg, 
cm 
5.15 
(4.53-5.69) 
5.46 
(4.80-5.93) 
4.83 
(4.43-5.37) 
0.006 
5.39 
(5.04-5.98) 
4.55 
(4.19-5.17) 
<0.001 
Anterior 
lower leg, 
cm 
2.57 
(2.33-2.81) 
2.81 
(2.61-3.11) 
2.40 
(2.27-2.58) 
<0.001 
2.55 
(2.33-2.79) 
2.60 
(2.40-2.89) 
0.201 
Posterior 
lower leg, 
cm 
5.68 
(5.09-6.22) 
6.19 
(5.60-6.89) 
5.14 
(4.84-5.55) 
<0.001 
5.81 
(5.37-6.26) 
5.48 
(4.78-6.19) 
0.060 
9-site total, 
cm 
24.69 
(22.12-28.61) 
28.64 
(27.08-31.54) 
22.83 
(21.28-24.53) 
<0.001 
27.46 
(23.53-30.11) 
22.83 
(21.06-26.68) 
<0.001 
IQR, interquartile range. 
 
 
  42 
Table 5. Descriptive summary of ultrasound measured muscle thickness using the 4-site protocol 
Variable 
Median 
(IQR) 
All 
(n=96) 
Males (n=41) 
Females 
(n=55) 
p-value 
Young 
(<60, n=55) 
Older 
(≥60, n=41) p-value 
4-site protocol – minimal compression 
Right mid-
point, cm 
4.07 
(3.36-4.80) 
4.59 
(3.98-5.32) 
3.51 
(2.95-4.26) 
<0.001 
4.43 
(4.06-5.12) 
3.37 
(2.75-3.89) 
<0.001 
Right lower 
third, cm 
3.04 
(2.43-3.72) 
3.53 
(3.00-4.29) 
2.71 
(2.12-3.25) 
<0.001 
3.48 
(3.01-4.18) 
2.46 
(2.01-2.97) 
<0.001 
Left mid-
point, cm 
3.97 
(3.29-4.70) 
4.67 
(3.95-4.99) 
3.67 
(2.96-4.05) 
<0.001 
4.30 
(3.92-4.97) 
3.26 
(2.83-3.95) 
<0.001 
Left lower 
third, cm 
3.08 
(2.41-3.71) 
3.65 
(2.91-4.24) 
2.72 
(2.16-3.21) 
<0.001 
3.45 
(3.00-4.17) 
2.39 
(2.06-2.91) 
<0.001 
Average, 
cm 
3.53 
(2.82-4.24) 
4.17 
(3.44-4.58) 
3.12 
(2.59-3.72) 
<0.001 
3.92 
(3.45-4.52) 
2.80 
(2.42-3.44) 
<0.001 
4-site protocol – maximal compression 
Right mid-
point, cm 
1.68 
(1.32-2.14) 
1.97 
(1.56-2.35) 
1.51 
(1.22-1.96) 
<0.001 
2.04 
(1.59-2.21) 
1.40 
(1.19-1.59) 
<0.001 
Right lower 
third, cm 
1.53 
(1.20-1.92) 
1.79 
(1.37-2.03) 
1.37 
(1.07-1.69) 
<0.001 
1.77 
(1.32-2.03) 
1.28 
(0.97-1.56) 
<0.001 
Left mid-
point, cm 
1.68 
(1.41-2.14) 
1.92 
(1.62-2.31) 
1.48 
(1.26-1.93) 
<0.001 
1.99 
(1.61-2.30) 
1.47 
(1.23-1.66) 
<0.001 
Left lower 
third, cm 
1.45 
(1.19-1.85) 
1.69 
(1.42-2.10) 
1.24 
(1.11-1.72) 
<0.001 
1.72 
(1.37-2.02) 
1.22 
(0.98-1.47) 
<0.001 
Average, 
cm 
1.56 
(1.30-1.98) 
1.93 
(1.48-2.18) 
1.37 
(1.17-1.85) 
<0.001 
1.86 
(1.51-2.18) 
1.32 
(1.15-1.53) 
<0.001 
IQR, interquartile range. 
5.2 Agreement between the 4-site protocol and DXA measures of lean tissue 
To assess how well ultrasound measured muscle thicknesses using the 4-site protocol 
represents DXA derived lean tissue, and to evaluate the level of compression (minimal or maximal) 
that was most accurate, site specific comparisons were performed as described above (section 4.4). 
Both minimal and maximal compression of the 4-site protocol are strongly associated (r>0.80) (92) 
with site specific DXA measures of lean tissue mass, but the r2 for minimal compression, r2=0.82, 
  43 
was significantly different compared to maximal compression, r2=0.66 (p<0.001) (Figure 9). 
Therefore, all further analysis was performed using minimal compression for the 4-site protocol. 
To determine the agreement between the 4-site protocol and DXA measured appendicular 
lean tissue, linear regression and Bland-Altman analysis was performed. Linear regression analysis, 
using the 4-site protocol, averaged across 3-fold cross-validation to predict appendicular lean tissue 
mass resulted in an adjusted r2 of 0.72 and SEE of 2.88 kg (Table 6). Bland-Altman analysis revealed 
normally distributed and homoscedastic differences (DXA – 4-site protocol) for appendicular lean  
Table 6. Linear regression analysis to predict appendicular lean tissue using the 4-site protocol  
Model 
development 
Appendicular lean tissue 
prediction (kg) 
Cross-validation 
fold 
Unadjusted 
r2 
Adjusted  
r2 
SEE 
(kg) 
p-value 
model 
Folds 1+2 4.061+(0.100X1) 3 0.72 0.71 2.93 <0.001 
Folds 1+3 4.037+(0.099X1) 2 0.73 0.72 2.84 <0.001 
Folds 2+3 3.587+(0.102X1) 1 0.75 0.74 2.86 <0.001 
Average 3.895+(0.100X1) - 0.73 0.72 2.88 - 
ALT, appendicular lean tissue; SEE, standard error of the estimate; X1 = 4-site muscle thickness x limb length (cm x cm). 
tissue. A significant (r2=0.08, p=0.005) proportional bias was present, with the 4-site protocol 
overestimating at the lower end and underestimating at the higher end of appendicular lean tissue; 
therefore, hyperbolic limits of agreement were constructed (Figure 10). The average range for the 
Figure 9. Regression analysis between site specific lean tissue mass derived from DXA and the 4-site ultrasound protocol 
using A) minimal compression, r2=0.82 and B) maximal compression, r2= 0.66. 
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hyperbolic limits of agreement, on the extreme ends (widest limits) of 10 and 35 kg of appendicular 
lean tissue, was 11.33 kg (11.35 for 10 kg and 11.3 for 35 kg). 
5.3 Agreement between the 9-site protocol and DXA measures of lean tissue 
Linear regression analysis, using the 9-site protocol, across the 3 cross-validation folds to 
predict appendicular lean tissue resulted in an average adjusted r2 of 0.90 and SEE of 1.73 kg 
(Appendix A2); this was the standard to achieve when optimizing the 4-site protocol. Bland-Altman 
Figure 10. Bland-Altman plot comparing DXA derived and 4-site predicted appendicular lean tissue mass, utilizing 
participants from all folds. A significant (p<0.05) proportional bias was present (solid black line, 95% CI - inner curved dashed 
lines), with 95% prediction intervals (outer curved dashed lines) with an average range on the highest (35 kg) and lowest (10 
kg) ends of appendicular lean tissue of 11.33 kg. Crosses (×) represent fold 1, closed circles (●) represent fold 2, and open 
circles (○) represent fold 3. 
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analysis revealed normally distributed and homoscedastic differences (DXA – 9-site protocol) for 
appendicular lean tissue, with no proportional bias present (p>0.05). A non-significant fixed bias of 
0.04 kg [95% CI: -0.34, 0.35 kg] was present with limits of agreement of -3.32 and 3.32 kg, and 
tolerance limits of -3.91 and 3.92 kg (Appendix A3). 
5.4 Agreement between optimized protocol and DXA measures of lean tissue 
To determine the variables to be included in the optimized ultrasound protocol, backwards 
stepwise regression was performed. Backwards stepwise regression identified the anterior upper arm 
x limb length, 4-site x limb length, age and sex as the covariates that were significantly associated 
with appendicular lean tissue. The anterior upper arm and 4-site muscle thicknesses were combined as 
a single variable (summed and multiplied by height) to simplify use; summed or separate muscle 
thickness inputs did not alter the results. Hereafter, this protocol (anterior upper arm + 4-site muscle 
thicknesses x height, age and sex) is referred to as the optimized 5-site protocol.  
Multi-linear regression analysis, using the variables for the optimized 5-site protocol, 
averaged across 3-fold cross-validation to predict appendicular lean tissue mass resulted in an r2 of  
Table 7. Multi-linear regression analysis to predict appendicular lean tissue using the optimized 5-site 
protocol  
Model 
development 
Appendicular lean tissue prediction (kg) 
Cross-
validation 
fold 
Unadjusted 
r2 
Adjusted 
r2 
SEE 
(kg) 
p-value 
model 
Folds 1+2 2.801+(1.564*X2)-(2.011*X3) +(0.0253*X4) 3 0.92 0.91 1.62 <0.001 
Folds 1+3 3.509+(1.507*X2)-(2.105*X3) +(0.0238*X4) 2 0.90 0.90 1.72 <0.001 
Folds 2+3 2.477+(1.594*X2)-(1.838*X3)+(0.0250*X4) 1 0.93 0.93 1.54 <0.001 
Average 2.929+(1.555*X2)-(1.985*X3) +(0.0247*X4) - 0.91 0.91 1.62 - 
SEE, standard error of the estimate. X2 = 5 site muscle thickness x height (cm x m), X3 = sex (male=0, female=1), X4 = age 
(years) 
0.91 and SEE of 1.62 kg (Table 7); identical to results obtained using the 9-site protocol. Bland-
Altman analysis revealed normally distributed and homoscedastic differences (DXA – optimized 5-
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site protocol) for appendicular lean tissue, with no proportion bias present (p<0.05). A non-significant 
fixed bias of 0.00 kg [95% CI: -0.33, 0.33 kg] was present with limits of agreement of -3.18 and 3.18 
kg, and tolerance limits of -3.75 and 3.75 kg (Figure 11). 
Figure 11. Bland-Altman plot comparing DXA derived and the optimized 5-site predicted appendicular lean tissue mass, 
utilizing participants from all folds. No fixed (0.00 [-0.33, 0.33]) or proportional bias was present (solid black line, 95% CI – 
inner short dashed line), with limits of agreement (1.96 SD) of -3.18 and 3.18 (middle long dashed lines) and tolerance 
limits of -3.75 and 3.75 (outer short dashed lines). Crosses (×) represent fold 1, closed circles (●) represent fold 2, and open 
circles (○) represent fold 3. 
Multi-logistic regression to identify individuals with lower than normal lean tissue mass, 
using the optimized 5-site protocol, across the model development folds resulted in an average odds 
ratio [95% CI] for the variables 5-site*height, sex and age of 0.255 [0.107, 0.613], 0.02 [0.001, 0.669] 
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and 0.972 [0.929, 1.017], respectively (Table 8). Across the cross-validation folds, an average 
concordance index of 0.89 [0.78, 1.00] was observed (Figure 12). 
Table 8. Logistic regression analysis to predict presence of low appendicular lean tissue using the 
optimized 5-site protocol 
Model 
Develo
pment 
Log Odds – low 
lean tissue 
Odds Ratio [95% CI] Cross- 
validati
on fold 
c-index 
[95% CI] 
5-site 
Sex 
(females=1) 
Age 
Folds 
1+2 
13.209-
(1.157*X2)-
(3.415*X3)-
(0.0217*X4) 
0.314 
[0.147, 0.674] 
0.033 
[0.001, 0.857] 
0.979 
[0.939, 1.020] 
3 
0.96  
[0.89, 1.00] 
Folds 
1+3 
17.914-
(1.554*X2)-
(4.380*X3)-
(0.0355*X4) 
0.211 
[0.079, 0.569] 
0.013 
[0.000, 0.501] 
0.965 
[0.917, 1.016] 
2 
0.85 
[0.71, 0.99] 
Folds 
2+3 
16.431-
(1.431*X2)-
(4.198*X3)-
(0.0275*X4) 
0.239 
[0.096, 0.596] 
0.015 
[0.000, 0.650] 
0.973 
[0.932, 1.016] 
1 
0.87  
[0.74, 1.00] 
Average 
15.851-
(1.381*X2)-
(3.998*X3)-
(0.0282*X4) 
0.255 
[0.107, 0.613] 
0.020 
[0.001, 0.669] 
0.972 
[0.929, 1.017] 
- 
0.89  
[0.78, 1.00] 
c-index, concordance index; CI, confidence interval. X2 = 5 site muscle thickness x height (cm x m), X3 = sex (male=0, 
female=1), X4 = age (years) 
Figure 12. ROC curves for folds 3, 2 and 1, utilizing the optimized 5-site protocol to identify lower than normal lean tissue mass 
identified by DXA cut-points. AUC for folds 3, 2 and 1 were 0.96, 0.85 and 0.87, respectively, average of 0.89. 
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5.5 Reliability of the 4-site protocol 
Intra-rater reliability for the 4-site protocol, assessing image acquisition and caliper 
placement, revealed CV and ICC [95% CI] using minimal compression of 1.1% and 0.998 [0.996, 
0.998] respectively, and for maximal compression, 2.5% and 0.989 [0.983, 0.993] (Table 9). Inter-
rater reliability of the 4-site protocol, assessing the entire ultrasound protocol, revealed CV and ICC 
using minimal compression of 3.7% and 0.988 [0.966, 0.996], respectively, and for maximal 
compression, 9.0% and 0.945 [0.843, 0.981] (Table 9). 
Table 9. Intra-rater and inter-rater reliability of the 4-site protocol 
 Intra-rater 
Compression Minimal Maximal 
ICC (1,1) [95% CI] 0.998 [0.996, 0.998] 0.989 [0.983, 0.993] 
CV (%) 1.1 2.5 
 Inter-rater 
Compression Minimal Maximal 
ICC (1,1) [95% CI] 0.988 [0.966, 0.996] 0.945 [0.843, 0.981] 
CV (%) 3.7 9.0 
CV, coefficient of variation; CI, confidence interval; ICC, intra-class correlation coefficient. 
Reliability was further assessed using Bland-Altman plots. Intra-rater plots, for both minimal 
and maximal compression revealed normal and homoscedastic differences (1st measure – 2nd measure) 
for the 4-site protocol, with proportional bias in a single plot (minimal compression, p<0.05). 
Minimal compression average bias [95% CI] for all intra-rater plots (except plot with proportional 
bias) was -0.04 [-0.03, 0.01 cm] and for maximal compression, a significant fixed bias of -0.02 [-0.04, 
-0.01 cm] (Appendix A5). Minimal compression average limits of agreement and tolerance limits 
were -0.14 and 0.12 cm and -0.16 and 0.14 cm and for maximal compression, -0.16 and 0.11 cm and -
0.18 and 0.14 cm (Appendix A6).  
Inter-rater Bland-Altman plot for minimal compression and maximal compression 
demonstrated normally distributed and homoscedastic differences (Rater BL – Rater MP) for the 4-
site protocol, with no proportional bias (p>0.05). For minimal compression, non-significant fixed bias 
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[95% CI] of -0.05 cm [-0.15, 0.05 cm], with limits of agreement and tolerance limits of -0.41 and 0.31 
cm and -0.58 and 0.49 cm, respectively (Figure 13). For maximal compression, non-significant fixed 
bias of -0.01 cm [-0.12, 0.11 cm], with limits of agreement and tolerance limits of -0.43 and 0.41 cm 
and -0.63 and 0.61 cm, respectively (Figure 13). 
 
  
Figure 13. Bland-Altman plots for inter-rater reliability using the 4-site protocol for A) minimal and B) maximal compression. A) 
Minimal compression: no fixed (-0.05 [-0.15, 0.05]) or proportional bias was present (solid black line, 95% CI – inner long dashed 
lines), with limits of agreement (1.96 SD) of -0.41 and 0.31 (middle short dashed lines) and tolerance limits of -0.58 and 0.49 (outer 
long dashed lines). B) Maximal compression: no fixed (-0.01 [-0.12, 0.11]) or proportional bias was present (solid black line, 95% CI 
– inner long dashed lines), with limits of agreement (1.96 SD) of -0.43 and 0.31 (middle short dashed lines) and tolerance limits of -
0.63 and 0.61 (outer long dashed lines). 
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Chapter 6 
Discussion, Future Directions and Conclusions 
6.1 Discussion 
This thesis sought to develop and internally validate a viable bedside ultrasound protocol to 
predict appendicular lean tissue mass and identify individuals with lower than normal lean tissue 
mass in a heterogeneous cohort of healthy participants. We demonstrated that a previously developed 
4-site protocol (2) is strongly (r2=0.72, SEE=2.88 kg) associated with DXA derived appendicular lean 
tissue mass and has excellent intra-rater and inter-rater reliability. However, by accounting for the 
anterior upper arm muscle thickness, sex and age in the regression analysis for the 4-site protocol, we 
observed improved model performance (r2=0.91, SEE=1.62 kg) for predicting appendicular lean 
tissue mass, while still developing a protocol that is feasible at the bedside. Interestingly, this 
optimized 5-site protocol matched the accuracy of the 9-site protocol (r2=0.90, SEE=1.73 kg), within 
this thesis, and demonstrated excellent ability to discriminate between low and normal lean tissue 
mass individuals (AUC=0.89). 
6.1.1 The 4-site protocol may have limited accuracy in predicting appendicular lean 
tissue mass 
As a first step, it was critical to demonstrate that ultrasound measured muscle thickness using 
the 4-site protocol was a valid representation of site specific lean tissue assessed using DXA. We 
observed strong associations when comparing average muscle thickness from the 4-site protocol 
(rectus femoris and vastus intermedialis) with site specific measures of lean tissue from DXA 
(average upper leg lean tissue mass for regions 1-4, Figure 6, page 30). This is in agreement with 
previous work which demonstrated that the muscle thickness of specific muscle groups (anterior 
upper arm, posterior upper arm, anterior upper leg and posterior lower leg) are strongly associated 
with their corresponding muscle volume measured using MRI (84). While both minimal and maximal 
  51 
compression were strongly associated with site specific lean tissue, minimal compression displayed a 
significantly stronger association compared to maximal compression, which has also recently been 
demonstrated in liver cirrhotic patients using the 4-site protocol (41). These results suggest that 
minimal compression measures of muscle thickness are valid estimates of lean tissue and may be 
more useful for predicting appendicular lean tissue mass compared with maximal compression.  
While a number of bedside applicable ultrasound protocols have been developed and utilized 
in various clinical populations, few have been compared to accurate whole body measures of lean 
tissue or muscle mass. Berger et al. (2015) observed that the muscle thickness at the midpoint of the 
rectus femoris, averaged across both legs, strongly associated (r2=0.55) with appendicular lean tissue 
mass measured by DXA. While similar landmarks were used in this thesis, the 4-site protocol is more 
comprehensive, imaging both the midpoint and lower third of the anterior thigh, representing rectus 
femoris and vastus intermedialis muscle thicknesses. These additional landmarks and depth of 
measurement (inclusive of the vastus intermedialis), in addition to accounting for limb length, may 
partly explain why we observed a stronger association (r2=0.72); especially since the participant 
cohorts recruited were quite similar, a combination of younger and older adults, of both sexes, with 
wide ranges of BMI (58). A more direct comparison of ultrasound protocols applied can be made to a 
previous collaborative investigation we published, in which the 4-site protocol was compared with 
CT based abdominal measures of muscle mass in 145 mixed medical and surgical critically ill 
patients (3). A moderate (r2 =0.20) correlation was observed, which may seem in direct opposition to 
the results from this thesis. However, this deviation may be explained by: 1) comparing a peripheral 
limb muscle thickness to an abdominal measure of muscle mass, which albeit was the most feasible 
approach for muscle mass validations in critically ill patients, and 2) utilizing maximal compression 
of the ultrasound probe against the skin, which this thesis and others (41) have demonstrated, may be 
less accurate than minimal compression (3). 
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While regression analysis is a necessary step since we are comparing two distinct tissue 
compartments, there are limitations with relying upon regression analysis as the sole indicator of 
model performance. Regression analysis examines how two measures relate to each other, and does 
not assess the absolute agreement at the individual level. It is therefore suggested to assess model 
performance using both regression and Bland-Altman analysis (93). Bland-Altman analysis involves 
clinically interpreting if the limits of agreement for the differences between methods represent an 
acceptable level of error. This is a rather difficult task for measures of lean tissue mass, as there is no 
currently defined clinically acceptable limits of agreement, and therefore, depending on what the 
authors consider an acceptable level of error, there may be large discrepancies in the interpretation of 
a Bland-Altman plots. 
One potential avenue to determine acceptable limits of agreement for ultrasound assessments 
of lean tissue is to examine literature utilizing Bland-Altman analysis of the 9-site protocol; as this 
can be considered the most accurate and comprehensive ultrasound protocol to date. Except for the 
initial study developing and cross-validating the 9-site protocol (48) (reference technique - 
hydrostatic weighing), every publication that has developed and tested the 9-site, or a subset of 
muscle thicknesses from the 9-site protocol, revealed limits of agreement no larger than ±4 kg (47; 
49; 52; 94). Therefore, limits of agreement that fall within ±4 kg may be a potential level of error to 
be considered acceptable for newly developed ultrasound protocols that predict lean tissue or muscle 
mass. However, the approach we are utilizing in this thesis is to accept limits of agreement based on 
the average difference between normal and low appendicular lean tissue mass individuals in a large 
cohort of community dwelling older adults. Scott et al. (2016), used previously published 
appendicular lean tissue cut-points (96) and observed that the average difference between normal and 
low lean tissue in 1100 Caucasian older adults (50-79 years old) was 3.3 kg, which was associated 
with an increased risk of falls. Therefore, when comparing DXA measured and ultrasound predicted 
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appendicular lean tissue mass (from the 4-site, 9-site and optimized 5-site protocols), Bland-Altman 
limits of agreement below ±3.3 kg will be considered an acceptable level of error. Within this 
participant cohort, 3.3 kg of appendicular lean tissue mass, when normalized average height squared, 
equates to 1.23 kg/m2 and 1.05 kg/m2 for females and males respectively. Comparing these values 
with previously established low lean tissue cut-points, 5.45 kg/m2 for females and 7.26 kg/m2 for 
males, demonstrates that a change corresponding to 3.3 kg of appendicular lean tissue may result in 
large discrepancies in the classification of individuals as low or normal lean tissue mass. Therefore, 
even if Bland-Altman analysis reveals limits of agreement below 3.3 kg, the ability to identify 
individuals with low lean tissue mass should be assessed, and ultimately, compared with measures of 
strength or physical function, to determine the usefulness of these measures for assessing functional 
status.  
Bland-Altman analysis for the 4-site protocol resulted in a proportional bias, and therefore 
hyperbolic limits of agreement were constructed as suggested previously (90; 93), making 
interpretation challenging. Here, we took a conservative approach and observed the range of 
differences for the 95% prediction interval (hyperbolic limits of agreement) at the widest points 
(highest and lowest values of appendicular lean tissue mass), observing ranges of 11.33 kg, or if we 
view this range similar to traditional limits of agreement, ±5.67 kg. Limits of agreement, of that 
magnitude, are quite similar to many single frequency BIA estimates of fat-free mass, often 
considered accurate for population averages (no fixed bias), but far too inaccurate for individual 
measures of fat-free mass (wide limits of agreement) (97). These limits of agreement are wider than 
our clinically acceptable limits of ±3.3 kg and, therefore, despite the strong associations (r2=0.72), the 
4-site protocol estimates of appendicular lean tissue would be considered an unacceptable level of 
error. 
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6.1.2 Distribution differences of lean tissue mass in a heterogeneous participant 
cohort increase the variability of 4-site protocol predictions 
Although the 4-site protocol, in this thesis, demonstrated strong associations with 
appendicular lean tissue (r2=0.72), there were wide limits of agreement and much unexplained 
variance. This level of error and unexplained variance for lean tissue predictions may partly be 
attributed to the participant cohort we recruited; as they were heterogeneous in terms of physical and 
demographic characteristics, such as age, sex and BMI. These physical and demographic 
characteristics may result in altered distribution of lean tissue mass between participants, which 
quadriceps muscle thickness is unable to account for. For example, there are sex-based differences in 
the distribution of skeletal muscle mass, such that females have approximately 70% of the muscle 
mass in the lower limbs in comparison to males, but only 50-60% for the upper limb musculature (73; 
98). Since the main outcome being predicted is appendicular lean tissue mass (upper and lower limb 
lean tissue), a lower limb muscle thickness will be unable to account for sex-based differences in the 
musculature of the upper limbs. On the other hand, aged individuals typically display increased 
atrophy of the lower limb musculature, relative to the upper limbs (73; 76; 99), and relying solely 
upon a lower limb muscle thickness, we would be unable to account for upper limb differences. BMI 
may also present a problem, particularly if DXA is used as the reference technique. Since DXA 
cannot distinguish muscle from lean tissue mass, and approximately 15-20% of adipose tissue is 
considered lean tissue (connective tissues) (5; 100), individuals with excess adiposity will have lean 
tissue that is unaccounted for from a measure of muscle thickness. Our participant cohort was 
intended to recruit males and females, with wide ranges of age, BMI and lean tissue mass for greater 
generalizability and this may have increased the variability seen with lean tissue mass predictions.  
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6.1.3 The 9-site protocol agrees with previous literature demonstrating high accuracy 
in predicting lean tissue mass 
Since the 9-site protocol is a comprehensive assessment of many muscle groups, it is not 
surprising that this protocol may be able to account for differences in lean tissue mass distributions 
based on sex and age. Here, we observed strong associations (r2=0.90, SEE=1.73) between the 9-site 
protocol and appendicular lean tissue mass; which is slightly lower, but similar (r2=0.94-0.97) to 
previous literature comparing the 9-site protocol to accurate measures of lean tissue or muscle mass 
(47; 49; 52). This slightly lower association may be attributed to our heterogeneous participant 
cohort, as previous studies have been performed in more homogeneous cohorts, focusing mainly on 
older or younger adults. Another potential issue that may have contributed to our lower association is 
with the subscapular landmark. Originally the 9-site protocol is performed in a standing posture, 
whereas all of our landmarking occurred in a supine or prone position, which may have imposed more 
variability on the position of the inferior angle of the scapula (more lateral translocation compared to 
a standing posture). This change in location of the landmark often led to lower than expected muscle 
thicknesses, which cannot be entirely accounted for due to a change in position from standing to 
supine (68). While the subscapular muscle thickness may have been altered due to landmarking 
issues, changes in posture, from standing to sitting, also alters measured muscle thickness for a 
number of landmarks for the 9-site protocol (68). English et al. (2009) determined that seven of the 
nine muscle thicknesses from the 9-site protocol are significantly reduced when measured in supine 
compared with standing position. Taken together, these issues may partly explain why a slightly 
lower association was observed in this thesis compared with previous literature. Although the 
regression analysis was slightly lower than previous publications, the limits of agreement (-3.32 and 
3.32 kg) were similar, as they fall below the ±4 kg generally seen with the 9-site protocol and below 
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our clinically defined limits of ±3.3 kg limits. Overall, the 9-site protocol, in a supine posture, can 
accurately predict appendicular lean tissue mass. 
6.1.4 The optimized 5-site protocol can accurately predict appendicular lean tissue 
mass 
While the 9-site protocol may be accurate, it cannot be easily applied at the bedside due to the 
inclusion of posterior landmarks, which would require a patient to be mobile or be moved to acquire 
those muscle thicknesses. We sought to optimize the accuracy of the 4-site protocol using bedside 
accessible muscle thicknesses from the 9-site protocol and easily obtained covariates that may 
influence appendicular lean tissue mass. The final optimized model included accounting for sex, age 
and the muscle thicknesses of the anterior upper arm and the 4-site protocol; interestingly, this model 
performed (r2=0.91) similar to the 9-site protocol (r2=0.90) for appendicular lean tissue predictions. A 
similar approach has been undertaken previously, Campbell et al. (1995), determined that the anterior 
thigh, anterior upper arm and anterior forearm, in a supine posture, strongly (r2=0.76) associated with 
whole body lean tissue mass measured by DXA. While similar muscle groups were imaged, we likely 
observed stronger associations because we accounted for age, sex and body proportions (height) and 
our comparison was against appendicular lean tissue mass, whereas Campbell and colleagues (1995), 
compared against whole body lean tissue mass.  
Optimization of the 4-site protocol with easily obtainable covariates has also been attempted 
previously. Two studies, comparing the 4-site protocol to abdominal muscle CSA, in ICU (3) and 
liver cirrhotic (41) patients, performed multi-variate regression using easily obtainable variables to 
improve model performance; within both models, BMI was included. Although potentially useful in a 
model to predict lean tissue, as weight is moderately associated with lean tissue mass (101), weight 
may be a rather difficult parameter to accurately obtain, depending on patient mobility/consciousness 
or the equipment available within a specific clinic. Therefore, a major advantage of our model is that 
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it is weight-independent, and can be entirely performed with the patient in a supine position, without 
requiring an accurate assessment of weight. However, a caveat for our model is that all participants’ 
heights were measured in a standing posture; whereas for a patient unable to stand, heights would be 
measured supine or estimated from anthropometric equations, which may result in additional 
variability of model performance. 
When examining Bland-Altman analysis for the optimized 5-site protocol, no significant 
fixed or proportional bias was present, and the limits of agreement (-3.18, 3.18 kg) are within the ±3.3 
kg clinically acceptable limits as described above. While the tolerance limits (upper and lower 95% 
confidence interval for the limits of agreement; -3.75, 3.75 kg) do not fall within the ±3.3 kg limits of 
agreement, they are still within the ±4 kg generally seen with the 9-site protocol. While the limits of 
agreement are generally used as the final decision of being acceptable, these wider tolerance limits 
demonstrate the need for external validation of the optimized 5-site protocol. We can therefore accept 
that the optimized 5-site protocol can accurately predict appendicular lean tissue mass on par with the 
9-site protocol. While the worst case scenario (for this participant cohort), a difference of 5.11 kg, 
would represent an unacceptable level of error and alter how this individual is identified as low or 
normal lean tissue, a difference of 5.11 kg represents over 3 standard deviation (less than 0.3% of 
individuals) difference from the mean, indicating a rather rare occurrence and would not alter the 
application of this protocol. 
6.1.5 Optimized 5-site protocol can accurately identify individuals with lower than 
normal lean tissue mass 
Using the optimized 5-site protocol, we observed a strong (AUC=0.89) ability to discriminate 
low and normal lean tissue individuals. Low lean tissue mass was identified using appendicular 
skeletal muscle index cut-points previously published by Baumgartner et al. (1998). While we 
recruited an expected proportion of low lean tissue mass individuals in the older adults (27%) (4; 
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101), a larger than expected proportion of individuals with low lean tissue mass was observed in our 
younger cohort (~11%), as we would expect approximately 2.5% of young individuals to fall below 2 
standard deviations of the average appendicular lean tissue of a young healthy reference group. 
Although surprising, this discrepancy may be partly explained by the fact that the original cut-points 
were developed in a cohort of young adults from 1986-1992, who may have led more active lifestyles 
in comparison to current physical activity levels (102). It is therefore difficult to exactly determine 
how these cut-points relate to poor physical function. 
Two previously discussed studies, using the 4-site protocol in ICU and liver cirrhotic patients, 
have also performed ROC curves to identify low muscle mass using CT based cut-points (3; 41). A 
wider variation in performance was observed, AUC=0.77 – 0.89, depending on patient cohort and 
sex, but still demonstrated moderate to strong ability to identify low muscle. While promising, these 
studies exhibit similar challenges to those presented in this thesis, the ultrasound models used to 
identify those individuals were developed and applied within the same cohort of individuals. 
Although we attempted to account for overfitting with cross-validation, external validation of these 
models is needed to ensure the usefulness of these measures in accurately identifying individuals with 
low lean tissue or muscle mass. 
6.1.6 The 4-site protocol demonstrates good reliability within and between raters 
All of the measures used for model training and cross-validations were performed by a single 
ultrasound operator, and it is therefore necessary to assess the reliability of these measures both 
within and between raters, as any given rater has influence on the landmarking, image acquisition and 
caliper placement, all of which may alter the final result. Reliability testing was only performed for 
the 4-site protocol because the development of the optimized 5-site protocol occurred following 
completion of data collection. Our results, ICC’s and CV’s for both minimal and maximal 
compression, agree with other studies demonstrating the strong reliability of the 4-site protocol (3; 
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56) and were consistent with a recent systematic review suggesting that ultrasound is a reliable 
modality to measure muscle thickness for numerous landmarks (82). For this thesis, intra-rater 
reliability was performed on previously defined landmarks, and therefore these results do not apply to 
the entire protocol To determine whether the intra-rater Bland-Altman limits of agreement (-0.14, 
0.12 cm) are acceptable, we examined the average change in the rectus femoris and vastus 
intermedialis muscle thicknesses after 3 days in the ICU from a recent ultrasound study, and 
determined that limits of agreement less than the average change over 3 days would be considered 
acceptable. Parry et al. (2016), observed that after 3 days in an ICU, a 10% reduction occurred in the 
rectus femoris and vastus intermedialis muscle thicknesses using similar landmarks to this thesis; 
which corresponded to a 0.435 cm loss compared to baseline values. Since our limits of agreement for 
minimal compression are smaller than the loss observed after 3 days in the ICU, we conclude that 
these are acceptable. Furthermore, utilizing the 4-site regression equation, changes in muscle 
thickness of 0.14 and 0.12, correspond to 0.63 kg and 0.54 kg of appendicular lean tissue mass, or 3% 
of the average appendicular lean tissue mass; further demonstrating the acceptable nature of these 
limits of agreement. This approach cannot be directly applied to the limits of agreement using 
maximal compression, as no studies have tracked changes in muscle thickness using maximal 
compression. But if we assume a theoretical 10% reduction over 3 days, it would result in a reduction 
of 0.13 cm (baseline maximal compression muscle thickness using the 4-site protocol in ICU patients 
(3)), which is smaller than the observed limits of agreement for maximal compression of the 4-site 
protocol (-0.16, 0.11 cm) and would be considered unacceptable.  
Our inter-rater results should be interpreted with caution due to the small sample size. But 
interestingly, we observed strong ICC’s and CV’s for both minimal and maximal compression, 
despite performing inter-rater reliability for the entire 4-site protocol. Similar results have been seen 
in acute stroke patients, where the entire protocol for the anterior upper leg using the 9-site protocol, 
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was shown to be reliably measured within the same rater (83). Although not assessed in this thesis, 
English et al. (2012) also demonstrated that the intra-rater reliability for the entire anterior upper arm 
protocol was also reliable. While the inter-rater reliability of the anterior upper arm needs to be 
assessed, these results are still promising for the reliability of the optimized 5-site protocol. Inter-rater 
Bland-Altman analysis revealed limits of agreement of -0.41 and 0.31 cm for minimal compression. 
Using the same approach as described above, our limits of agreement are again smaller than the 3 day 
reduction in muscle thickness for ICU patients and therefore are considered acceptable. Applying 
these limits of agreement to the 4-site regression equation results in changes of 1.8 kg and 1.4 kg of 
appendicular lean tissue mass, or 9% of the average appendicular lean tissue mass; which is below a 
commonly suggested cutoff of 10% (93). However, for maximal compression, the limits of 
agreement, -0.43 and 0.41 cm, are much wider than the theoretical muscle thickness loss of 0.13 cm 
and would be considered unacceptable. Overall, minimal compression demonstrates stronger 
reliability than maximal compression, in addition to being more accurate, and should therefore be 
utilized moving forward. 
The participant cohort that had inter-rater reliability measures performed was a group of 
predominately older adults, alternating between dominant and non-dominant legs to ensure the 
potentially higher quality muscle was not over represented. While these results may only apply to 
older adults, we suspect the results may be further improved if performed on a younger group of 
individuals, since they tend to have lower body fat, allowing easier identification of bony landmarks. 
6.1.7 Limitations 
While these results are promising, this thesis has a number of limitations, in addition to those 
discussed above. When landmarking for the 4-site protocol, a straight line connecting the anterior 
superior iliac spine and the mid-upper patella is used as central vertical line for the ultrasound 
transducer to image. In some cases, this landmarking approach may not line up directly on the rectus 
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femoris and vasutus intermedialis (Appendix A4), providing a less than ideal muscle thickness (i.e. 
not measuring the greatest thickness of the muscle belly). In future investigations, allowing lateral 
movement of the ultrasound transducer to image the ideal landmark may further reduce the variability 
in predicting appendicular lean tissue. Second, no participants in this thesis were categorized as being 
underweight (BMI<18.5 kg/m2), which may limit the applicability of these results to those individuals 
who may be on the lowest end of the appendicular lean tissue spectrum; but, even in the majority of 
clinical populations, typically less than 10% of patients fall below 18.5 kg/m2 (103). Furthermore, the 
older adult cohort that was recruited was a high functioning group of individuals and therefore these 
results may not be generalizable to those older adults that are potentially at higher risk of poor 
physical function. Fourth, the reliability results should be interpreted with caution, due to both a small 
sample size and because all analysis was performed using two fixed raters. Due to having two fixed 
raters, with averaged muscle thicknesses for each landmark, it has been suggested to apply the ICC 
(3,2) equation, which give the highest values, but is the least generalizable (87), whereas others 
suggest applying the more conservative ICC (1,1) equation (104). Regardless of which equation is 
applied, the design of using two fixed raters would only allow generalization of these results to these 
specific raters, and not others, limiting the applicability of these reliability results. Lastly, we assume 
that any unexplained variation or error is associated with the ultrasound measures, and that there is no 
inherent error or variability with DXA measures of appendicular lean tissue. While DXA is rather 
precise (<2% CV for lean tissue) technique, there are still a number of limitations associated with its 
use. Specific to this thesis, we had a number of individuals with high body fat, which may have added 
lean tissue mass that muscle thickness measures will not account for, as discussed above (section 
6.1.2).  
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6.2 Future directions 
While this thesis has focused on developing an accurate, yet viable, bedside ultrasound 
protocol to assess appendicular lean tissue and identify individuals who may be at risk of low lean 
tissue mass, ultimately these measures need to be validated in specific clinical populations, to ensure 
they accurately and reliability identify those individuals who require nutritional or rehabilitative 
therapies targeted to improve muscle mass or function. Prior to that end goal, to ensure that the 
approach taken in this thesis is an accurate model, external validation of the optimized 5-site protocol 
would be ideal, both for prediction of appendicular lean tissue and identification of low lean tissue 
mass. Alongside that external validation study, a more robust reliability study design should be 
undertaken, involving much larger sample sizes and incorporating a wider array of randomly selected 
raters to ensure the generalizability of those findings. Following those external validation and 
reliability studies, it would be necessary to assess if the optimized 5-site protocol can: 1) determine if 
the participants identified as having lower than normal lean tissue mass display poorer physical 
function and 2) assess the ability to detect changes in muscle or lean tissue mass overtime.  
External validation of the optimized 5-site protocol should be ideally performed in a similar 
heterogeneous participant cohort; but active recruitment of individuals in the underweight BMI (≤ 
18.5 kg/m2) category may increase the proportion of individuals identified as being lower than normal 
lean tissue or muscle mass, which would improve the validity of the ROC analysis and increase the 
generalizability of the model. One aspect that should be accounted for in future designs, is ethnicity, 
as equations developed in Japanese populations perform poorly in Caucasian adults (49). While it is 
difficult to speculate on the potential causes of this discrepancy, it is not an uncommon issue, as 
Asian specific thresholds for BMI categories and CT based low muscle mass have been suggested 
(105; 106). Future external validation studies should attempt to stratify their participants by ethnicity 
or develop population specific equations. This external validation study could also further improve 
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upon the protocol, by allowing lateral movement of the 4-site landmarks to obtain the ideal muscle 
thickness for all individuals. Alongside that external validation study, a robust reliability study could 
be performed as well, in which numerous raters are utilized to assess the entire optimized 5-site 
protocol. The protocol should be broken down into three steps, landmarking, image acquisition and 
caliper placement. By using a digitizing probe (i.e. Optotrak) for landmarking, agreement for both 
palpation of bony surfaces and final landmark location can be assessed between raters. For image 
acquisition, a predefined landmark can be used for raters to acquire ultrasound scans of the 
underlying muscle groups. A single trained investigator can then quantify each scan for muscle 
thickness measures, to assess the agreement of raters in obtaining similar scans. For caliper 
placement, a single image, acquired from a single trained rater can be analyzed using offline image 
analysis software by different raters, to compare agreement in muscle thickness values. This 
comprehensive reliability setup would allow generalizability of these results, and determine which 
steps require further standardization to improve the applicability of these measures across multiple 
centres. 
 While accurate and reliable identification of individuals with low lean tissue mass using the 
optimized 5-site protocol is important, it is also crucial to determine if these individuals also display 
poor physical function. Comparing measures of strength and physical function between those 
individuals identified as low or normal lean tissue mass would determine whether the optimized 5-site 
protocol can identify not only low lean tissue, but also sarcopenic individuals (low muscle and poor 
strength or function). Ideally this cohort of individuals would consist of males and females, with a 
wide range of age and BMI, to ensure the generalizability of these results. The age factor is important 
to account for since older adults will have poorer strength and function, and these results may only be 
applicable to these individuals. BMI on the other hand may be important to account for due to an 
interesting theme that is gaining more attention, accounting for fat mass, alongside muscle mass, for 
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identifying individuals with poor function (107; 108). Previous studies, incorporating appendicular fat 
mass, into the assessment of low lean tissue using DXA resulted in better identification of individuals 
with poor physical function (108). This may be due to requiring more muscle mass for a given 
function if there is excess adiposity, due to poorer quality muscle in those individuals who are 
overweight or obese, or perhaps even associated with the limitation of DXA assessing the lean tissue 
components of adipose tissue. Regardless, moving forward, a potentially useful variable to include 
when attempting to identify individuals with poor physical function may be adipose tissue thickness; 
as it has been demonstrated that using adipose thickness from a variety of landmarks, can accurately 
predict whole body fat mass (44).   
 Lastly, it is necessary to accurately assess changes in muscle or lean tissue mass overtime. 
The sensitivity of the optimized 5-site protocol to detect meaningful changes should be assessed; this 
would allow researchers and clinicians to determine if nutritional or rehabilitative interventions result 
in improvements in muscle mass and quality or to determine if there is further deterioration of 
musculature. Assessing the agreement in changes of muscle quantity using the optimized 5-site 
ultrasound protocol, during both disuse induced atrophy (bed rest) and exercise related hypertrophy 
(resistance training), with changes quantified using accurate modalities (i.e. DXA, MRI), would 
reveal whether changes in the muscle thicknesses of the anterior upper arm and 4-site protocol 
(landmarks utilized in the optimized 5-site protocol) are representative of whole body changes in 
muscle or lean tissue mass.     
6.3 Conclusions 
This thesis developed and internally validated an accurate viable, bedside ultrasound protocol 
to predict appendicular lean tissue mass in a heterogeneous cohort of young and older adults. We 
have shown that minimal compression is more accurate than maximal compression of the 4-site 
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protocol for prediction of lean tissue mass; moving forward, for lean tissue estimates, minimal 
compression should be used. The previously developed 4-site protocol is strongly associated with 
appendicular lean tissue mass, but Bland-Altman analysis revealed wide limits of agreement and 
proportional bias; demonstrating that the 4-site protocol alone may not accurately predict 
appendicular lean tissue mass. We determined that the muscle thicknesses of the anterior upper arm 
and 4-site quadriceps protocols, in addition to sex and age, are important variables in predicting lean 
tissue and demonstrated that this optimized 5-site protocol can accurately predict appendicular lean 
tissue mass and identify individuals with lower than normal lean tissue mass. These results 
demonstrate that this viable bedside protocol may be useful for assessing lean tissue mass in clinical 
settings, but external validation in clinical populations is necessary to ensure the robustness of these 
findings. 
  
  66 
References 
1. Mourtzakis M, Wischmeyer P (2014): Bedside ultrasound measurement of skeletal muscle. Curr 
Opin Clin Nutr Metab Care. 17: 389–95. 
2. Gruther W, Benesch T, Zorn C, Paternostro-Sluga T, Quittan M, Fialka-Moser V, et al. (2008): 
Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris 
muscle layer. J Rehabil Med. 40: 185–9. 
3. Paris M, Mourtzakis M, Day A, Leung R, Watharkar S, Kozar R, et al. (2016): VALIDation of 
bedside Ultrasound of Muscle layer thickness of the quadriceps in the critically ill patient 
(VALIDUM study): A prospective multicenter study. J Parenter Enter Nutr. . doi: 
10.1177/0148607116637852. 
4. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. (1998): 
Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 147: 755–63. 
5. Prado C, Heymsfield SB (2014): Lean Tissue Imaging: A New Era for Nutritional Assessment and 
Intervention. JPEN J Parenter Enteral Nutr. 38: 940–53. 
6. Moisey LL, Mourtzakis M, Cotton B a, Premji T, Heyland DK, Wade CE, et al. (2013): Skeletal 
muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit 
Care. 17: R206. 
7. Filippin LI, Teixeira VNDO, da Silva MPM, Miraglia F, da Silva FS (2015): Sarcopenia: a 
predictor of mortality and the need for early diagnosis and intervention. Aging Clin Exp Res. 27: 
249–54. 
8. Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian S a, Frank I, et al. (2014): Sarcopenia 
in patients with bladder cancer undergoing radical cystectomy: impact  on cancer-specific and 
all-cause mortality. Cancer. . doi: 10.1002/cncr.28798. 
9. Greening N, Harvey-Dunstan T, Chaplin E, Vincent E, Morgan M, Singh S, Steiner M (2015): 
Bedside assessment of quadriceps muscle using ultrasound following admission for acute 
exacerbations of chronic respiratory disease. Am J Respir Crit Care Med. 192: 810–816. 
10. Leenders M, Verdijk LB, van der Hoeven L, Adam JJ, van Kranenburg J, Nilwik R, Van Loon 
LJC (2013): Patients with type 2 diabetes show a greater decline in muscle mass, muscle 
  67 
strength, and functional capacity with aging. J Am Med Dir Assoc. 14: 585–592. 
11. Di Sebastiano KM, Yang L, Zbuk K, Wong RK, Chow T, Koff D, et al. (2013): Accelerated 
muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the 
relationship with diabetes and anaemia. Br J Nutr. 109: 302–12. 
12. Seymour JM, Ward K, Sidhu PS, Puthucheary Z, Steier J, Jolley CJ, et al. (2009): Ultrasound 
measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength 
in COPD. Thorax. 64: 418–423. 
13. Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, et al. (2014): Sarcopenia 
impairs prognosis of patients with liver cirrhosis. Nutrition. 31: 193–199. 
14. Reid C, Campbell I, Little R (2004): Muscle wasting and energy balance in critical illness. Clin 
Nutr. 23: 273–80. 
15. Morley JE (2012): Sarcopenia in the elderly. Fam Pract. 29: 44–48. 
16. Kirk PS, Friedman JF, Cron DC, Terjimanian MN, Wang SC, Campbell D a., et al. (2015): One-
year postoperative resource utilization in sarcopenic patients. J Surg Res. . doi: 
10.1016/j.jss.2015.04.074. 
17. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004): The Healthcare Costs of Sarcopenia 
in the United States. J Am Geriatr Soc. 52: 80–85. 
18. Heymsfield SB, Wang Z, Baumgartner RN, Ross R (1997): Human body composition: advances 
in models and methods. Annu Rev Nutr. 17: 527–558. 
19. Lee R, Wang Z, Heymsfield SB (2001): Skeletal Muscle Mass and Aging: Regional and Whole-
Body Measurement Methods. Can J Appl Physiol. 26: 102–122. 
20. Chen Z, Wang Z, Lohman T, Heymsfield SB, Outwater E, Nicholas JS, et al. (2007): Dual-energy 
X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J Nutr. 
137: 2775–2780. 
21. Geisler C, Pourhassan M, Braun W, Schweitzer L, Müller MJ (2015): The prediction of total 
skeletal muscle mass in a Caucasian population - comparison of Magnetic resonance imaging 
(MRI) and Dual-energy X-ray absorptiometry (DXA). Clin Physiol Funct Imaging. 2. doi: 
10.1111/cpf.12282. 
  68 
22. Genton L, Hans D, Kyle UG, Pichard C (2002): Dual-Energy X-ray absorptiometry and body 
composition: differences between devices and comparison with reference methods. Nutrition. 
18: 66–70. 
23. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D (2002): Total-body skeletal 
muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J ClinNutr. 
76: 378–383. 
24. LaForgia J, Dollman J, Dale MJ, Withers RT, Hill AM (2009): Validation of DXA body 
composition estimates in obese men and women. Obesity (Silver Spring). 17: 821–826. 
25. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, Pierson Jr. RN (1990): 
Appendicular skeletal muscle mass:  Measurement by dual- photon absorptiometry. Am J Clin 
Nutr. 52: 214–218. 
26. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. (2010): 
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working 
Group on Sarcopenia in Older People. Age Ageing. 39: 412–23. 
27. Visser M, Kritchevsky S, Goodpaster B, Newman AB, Nevitt MC, Stamm E, Harris TB (2002): 
Leg Muscle Mass and Composition in Relation to Lower Extremity Performance in Men and 
Women Aged 70 to 79: The Health, Aging and Body Composition Study. J Am Geriatr Soc. 50: 
897–904. 
28. Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CMM, Baracos VE (2009): A 
viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions 
of organ and tumor mass to whole-body energy demands. Am J Clin Nutr. 89: 1173–1179. 
29. Lifshitz F, Hecht JP, Bermúdez EF, Gamba CA, Reinoso JM, Casavalle PL, et al. (2016): Body 
composition analysis by dual-energy X-ray absorptiometry in young preschool children. Eur J 
Clin Nutr. 1–7. 
30. Nana, Alisa; Slater, Gary; Stewart, Arthur & Burke L (2014): Methology review: Uisng dual-
energy x-ray absorptiometry (DXA) for the assessment of body composition in athletes and 
active people. Int J Sport Nutr Exerc. 1–44. 
31. Oldroyd B, Smith  a H, Truscott JG (2003): Cross-calibration of GE/Lunar pencil and fan-beam 
dual energy densitometers--bone mineral density and body composition studies. Eur J Clin Nutr. 
  69 
57: 977–987. 
32. Toombs RJ, Ducher G, Shepherd JA, De Souza MJ (2012): The impact of recent technological 
advances on the trueness and precision of DXA to assess body composition. Obesity (Silver 
Spring). 20: 30–9. 
33. Paris M, Mourtzakis M (2016): Assessment of skeletal muscle mass in critically ill patients. Curr 
Opin Clin Nutr Metab Care. 19: 125–130. 
34. Tandon P, Ney M, Irwin I, Ma M, Gramlich L, Bain V, et al. (2012): Severe Muscle Depletion in 
Patients on the Liver Transplant Wait List: Its Prevalence and Independent Prognostic Value. 
Liver Transplant. 18: 1209–1216. 
35. Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A (2015): Markers 
of sarcopenia quantified by computed tomography predict adverse long-term outcome in 
patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. . doi: 
10.1007/s00330-015-3963-1. 
36. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R (1998): 
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and 
computerized tomography. J Appl Physiol. 85: 115–122. 
37. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge M-P, Albu J, et al. (2004): Total body 
skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional 
image. J Appl Physiol. 97: 2333–8. 
38. Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE (2008): A 
practical and precise approach to quantification of body composition in cancer patients using 
computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 33: 997–
1006. 
39. Weijs PJM, Looijaard WGPM, Dekker IM, Stapel SN, Girbes AR, Oudemans-van Straaten HM, 
Beishuizen A (2014): Low skeletal muscle area is a risk factor for mortality in mechanically 
ventilated critically ill patients. Crit Care. 18: 1–7. 
40. Baracos V, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S (2010): Body composition in 
patients with non–small cell lung cancer: a contemporary view of cancer cachexia with the use 
of computed tomography image analysis. Am J Clin Nutr. 91: 1133–1137. 
  70 
41. Tandon P, Low G, Mourtzakis M, Zenith L, Myers R, Abraldes J, et al. (2016): A Model to 
Identify Sarcopenia in Patients with Cirrhosis. Clin Gastroenterol Hepatol. . doi: 
10.1016/j.toxicon.2008.05.012. 
42. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008): 
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the 
respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 9: 629–635. 
43. Zaidman CM, Wu JS, Wilder S, Darras BT, Rutkove SB (2014): Minimal training is required to 
reliably perform quantitative ultrasound of muscle. Muscle Nerve. 50: 124–8. 
44. Wagner DR (2013): Ultrasound as a tool to assess body fat. J Obes. 2013. doi: 
10.1155/2013/280713. 
45. Topchyan A, Tatarinov A, Sarvazyan N, Sarvazyan A (2006): Ultrasound velocity in human 
muscle in vivo: Perspective for edema studies. Ultrasonics. 44: 259–264. 
46. Cartwright MS, Demar S, Griffin LP, Balakrishnan N, Harris JM, Walker FO (2013): Validity 
and reliability of nerve and muscle ultrasound. Muscle Nerve. 47: 515–21. 
47. Takai Y, Ohta M, Akagi R, Kato E, Wakahara T, Kawakami Y, et al. (2014): Applicability of 
ultrasound muscle thickness measurements for predicting fat-free mass in elderly population. J 
Nutr Health Aging. 18: 579–85. 
48. Abe T, Kondom M, Kawakami Y, Fukunaga T (1994): Prediction Equations for Body 
Composition of Japanese Adults by B-mode Ultrasound. Am J Hum Biol. 170: 161–170. 
49. Sanada K, Kearns CF, Midorikawa T, Abe T (2006): Prediction and validation of total and 
regional skeletal muscle mass by ultrasound in Japanese adults. Eur J Appl Physiol. 96: 24–31. 
50. Johnson KE, Miller B, Juvancic-Heltzel J a, Agnor SE, Kiger DL, Kappler RM, Otterstetter R 
(2014): Agreement between ultrasound and dual-energy X-ray absorptiometry in assessing 
percentage body fat in college-aged adults. Clin Physiol Funct Imaging. 34: 493–6. 
51. Schoenfeld BJ, Aragon AA, Moon J, Krieger JW, Tiryaki-Sonmez G (2016): Comparison of 
amplitude-mode ultrasound versus air displacement plethysmography for assessing body 
composition changes following participation in a structured weight-loss programme in women. 
Clin Physiol Funct Imaging. . doi: 10.1111/cpf.12355. 
52. Toda Y, Kimura T, Taki C, Kurihara T, Homma T, Hamaoka T, Sanada K (2016): New 
  71 
ultrasonography-based method for predicting total skeletal muscle mass in male athletes. J Phys 
Ther Sci. 28: 1556–1559. 
53. Abe T, Dabbs NC, Nahar VK, Ford MA, Bass M a., Loftin M (2013): Relationship between Dual-
Energy X-Ray Absorptiometry-Derived Appendicular Lean Tissue Mass and Total Body 
Skeletal Muscle Mass Estimated by Ultrasound. Int J Clin Med. 04: 283–286. 
54. Abe T, Thiebaud RS, Loenneke JP, Young KC (2015): Prediction and validation of DXA-derived 
appendicular lean soft tissue mass by ultrasound in older adults. Age (Omaha). 37: 1–10. 
55. Kendall KL, Fukuda DH, Hyde PN, Smith-Ryan AE, Moon JR, Stout JR (2016): Estimating fat-
free mass in elite-level male rowers: a four-compartment model validation of laboratory and 
field methods. J Sports Sci. 0414: 1–10. 
56. Tillquist M, Kutsogiannis DJ, Wischmeyer PE, Kummerlen C, Leung R, Stollery D, et al. (2014): 
Bedside ultrasound is a practical and reliable measurement tool for assessing quadriceps muscle 
layer thickness. JPEN J Parenter Enteral Nutr. 38: 886–90. 
57. Agyapong-Badu S, Warner M, Samuel D, Narici M, Cooper C, Stokes M (2014): Anterior thigh 
composition measured using ultrasound imaging to quantify relative thickness of muscle and 
non-contractile tissue: a potential biomarker for musculoskeletal health. Physiol Meas. 35: 
2165–76. 
58. Berger J, Bunout D, Barrera G, de la Maza MP, Henriquez S, Leiva L, Hirsch S (2015): Rectus 
femoris (RF) ultrasound for the assessment of muscle mass in older people. Arch Gerontol 
Geriatr. . doi: 10.1016/j.archger.2015.03.006. 
59. Takai Y, Ohta M, Akagi R, Kato E, Wakahara T, Kawakami Y, et al. (2013): Validity of 
ultrasound muscle thickness measurements for predicting leg skeletal muscle mass in healthy 
Japanese middle-aged and older individuals. J Physiol Anthropol. 32: 12. 
60. Campbell IT, Watt T, Withers D, England R, Sukumar S, Keegan M, et al. (1995): Muscle 
thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple 
organ failure in the presence of edema. Am J Clin Nutr. 62: 533–539. 
61. Rosenberg JG, Ryan ED, Sobolewski EJ, Scharville MJ, Thompson BJ, King GE (2014): 
Reliability of panoramic ultrasound imaging to simultaneously examine muscle size and quality 
of the medial gastrocnemius. Muscle Nerve. 49: 736–40. 
  72 
62. Puthucheary Z a, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. (2013): Acute 
skeletal muscle wasting in critical illness. JAMA. 310: 1591–600. 
63. Reeves ND, Maganaris CN, Narici M V (2004): Ultrasonographic assessment of human skeletal 
muscle size. Eur J Appl Physiol. 91: 116–8. 
64. Franchi M V, Atherton PJ, Reeves ND, Flück M, Williams J, Mitchell WK, et al. (2014): 
Architectural, functional and molecular responses to concentric and eccentric loading in human 
skeletal muscle. Acta Physiol (Oxf). 210: 642–54. 
65. Abe T, Loenneke JP, Young KC, Thiebaud RS, Nahar VK, Hollaway KM, et al. (2014): Validity 
of Ultrasound Prediction Equations for Total and Regional Muscularity in Middle-aged and 
Older Men and Women. Ultrasound Med Biol. 1–8. 
66. Midorikawa T, Ohta M, Hikihara Y, Torii S, Sakamoto S (2015): Prediction and validation of 
total and regional skeletal muscle volume using B-mode ultrasonography in Japanese 
prepubertal children. Br J Nutr. 114: 1209–1217. 
67. Altman DG, Bland JM (1983): Measurement in Medicine : the Analysis of Method Comparison 
Studies. Statistician. 32: 307–317. 
68. Thoirs K, English C (2009): Ultrasound measures of muscle thickness: intra-examiner reliability 
and influence of body position. Clin Physiol Funct Imaging. 29: 440–6. 
69. Parry SM, El-Ansary D, Cartwright MS, Sarwal A, Berney S, Koopman R, et al. (2015): 
Ultrasonography in the intensive care setting can be used to detect changes in the quality and 
quantity of muscle and is related to muscle strength and function. J Crit Care. 30: 1151.e9–
1151.e14. 
70. Ismail C, Zabal J, Hernandez HJ, Woletz P, Manning H, Teixeira C, et al. (2015): Diagnostic 
ultrasound estimates of muscle mass and muscle quality discriminate between women with and 
without sarcopenia. Front Physiol. 6: 1–10. 
71. Minetto MA, Caresio C, Menapace T, Hajdarevic A, Marchini A, Molinari F, Maffiuletti NA 
(2015): Ultrasound-Based Detection of Low Muscle Mass for Diagnosis of Sarcopenia in Older 
Adults. PM R. 1–10. 
72. Kuyumcu ME, Halil M, Kara Ö, Çuni B, Çağlayan G, Güven S, et al. (2016): Ultrasonographic 
Evaluation of the Calf Muscle Mass and Architecture in Elderly Patients With and Without 
  73 
Sarcopenia. Arch Gerontol Geriatr. 65: 218–224. 
73. Janssen I, Heymsfield SB, Wang Z, Ross R (2000): Skeletal muscle mass and distribution in 468 
men and women aged 18–88 yr. J Appl Physiol. 89: 81–88. 
74. Abe T, Thiebaud RS, Loenneke JP, Loftin M, Fukunaga T (2014): Prevalence of site-specific 
thigh sarcopenia in Japanese men and women. Age (Dordr). 36: 417–26. 
75. Abe T, Patterson KM, Stover CD, Geddam D a R, Tribby AC, Lajza DG, Young KC (2014): Site-
specific thigh muscle loss as an independent phenomenon for age-related muscle loss in middle-
aged and older men and women. Age (Dordr). 36: 9634. 
76. Abe T, Loenneke JP, Thiebaud RS, Fukunaga T (2014): Age-related site-specific muscle wasting 
of upper and lower extremities and trunk in Japanese men and women. Age (Dordr). 36: 813–
21. 
77. Harris-Love MO, Monfaredi R, Ismail C, Blackman MR, Cleary K (2014): Quantitative 
ultrasound: measurement considerations for the assessment of muscular dystrophy and 
sarcopenia. Front Aging Neurosci. 6: 172. 
78. Koskelo E-K, Kivisaari LM, Saarinen UM, Siimes M a. (1991): Quantitation of Muscles and Fat 
by Ultrasonography: A Useful Method in the Assessment of Malnutrition in Children. Acta 
Paediatr. 80: 682–687. 
79. Ema R, Wakahara T, Mogi Y, Miyamoto N, Komatsu T, Kanehisa H, Kawakami Y (2013): In 
vivo measurement of human rectus femoris architecture by ultrasonography: Validity and 
applicability. Clin Physiol Funct Imaging. 33: 267–273. 
80. Jenkins NDM, Miller JM, Buckner SL, Cochrane KC, Bergstrom HC, Hill EC, et al. (2015): 
Test–Retest Reliability of Single Transverse versus Panoramic Ultrasound Imaging for Muscle 
Size and Echo Intensity of the Biceps Brachii. Ultrasound Med Biol. 41: 1584–1591. 
81. Schneebeli A, Egloff M, Giampietro A, Clijsen R, Barbero M (2014): Rehabilitative ultrasound 
imaging of the supraspinatus muscle: Intra- and interrater reliability of thickness and cross-
sectional area. J Bodyw Mov Ther. 18: 266–272. 
82. English C, Fisher L, Thoirs K (2012): Reliability of real-time ultrasound for measuring skeletal 
muscle size in human limbs in vivo: a systematic review. Clin Rehabil. 26: 934–944. 
83. English CK, Thoirs KA, Fisher L, McLennan H, Bernhardt J (2012): Ultrasound is a reliable 
  74 
measure of muscle thickness in acute stroke patients, for some, but not all anatomical sites: a 
study of the intra-rater reliability of muscle thickness measures in acute stroke patients. 
Ultrasound Med Biol. 38: 368–76. 
84. Miyatani M, Kanehisa H, Ito M, Kawakami Y, Fukunaga T (2004): The accuracy of volume 
estimates using ultrasound muscle thickness measurements in different muscle groups. Eur J 
Appl Physiol. 91: 264–72. 
85. Fukumoto Y, Ikezoe T, Yamada Y, Tsukagoshi R, Nakamura M, Mori N, et al. (2012): Skeletal 
muscle quality assessed from echo intensity is associated with muscle strength of middle-aged 
and elderly persons. Eur J Appl Physiol. 112: 1519–25. 
86. So JL, Janssen I, Heymsfield SB, Ross R (2004): Relation between whole-body and regional 
measures of human skeletal muscle. Am J Clin Nutr. 80: 1215–1221. 
87. Rankin G, Stokes M (1998): Reliability of assessment tools in rehabilitation: an illustration of 
appropriate statistical analyses. Clin Rehabil. 12: 187–199. 
88. Kohavi R (1995): A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model 
Selection. Int Jt Conf Artif Intell. 14: 1137–1143. 
89. Bland JM, Altman DG (1999): Measuring agreement in method comparison studies. Stat Methods 
Med Res. 8: 135–160. 
90. Ludbrook J (2010): Confidence in Altman-Bland plots: A critical review of the method of 
differences. Clin Exp Pharmacol Physiol. 37: 143–149. 
91. Chhapola V, Kanwal SK, Brar R (2015): Reporting standards for Bland-Altman agreement 
analysis in laboratory research: a cross-sectional survey of current practice. Ann Clin Biochem. 
52: 382–6. 
92. Steyerberg EW (2008): Clinical prediction models. Stat Biol Heal. . doi: 10.1007/978-0-387-
77244-8. 
93. Earthman CP (2015): Body Composition Tools for Assessment of Adult Malnutrition at the 
Bedside: A Tutorial on Research Considerations and Clinical Applications. J Parenter Enter 
Nutr. (Vol. 39). doi: 10.1177/0148607115595227. 
94. Abe T, Fujita E, Thiebaud RS, Loenneke JP, Akamine T (2016): Ultrasound-Derived Forearm 
Muscle Thickness Is a Powerful Predictor for Estimating DXA-Derived Appendicular Lean 
  75 
Mass in Japanese Older Adults. Ultrasound Med Biol. 1–4. 
95. Scott D, Chandrasekara SD, Laslett LL, Cicuttini F, Ebeling PR, Jones G (2016): Associations of 
Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures 
Over 5–10 Years in Community-Dwelling Older Adults. Calcif Tissue Int. 99: 1–13. 
96. Scott D, Sanders KM, Aitken D, Hayes A, Ebeling PR, Jones G (2014): Sarcopenic obesity and 
dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity. 
22: 1568–1574. 
97. Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000): Estimation of skeletal muscle mass 
by bioelectrical impedance analysis. J Appl Physiol. 89: 465–471. 
98. Abe T, Kearns CF, Fukunaga T (2003): Sex differences in whole body skeletal muscle mass 
measured by magnetic resonance imaging and its distribution in young Japanese adults. Br J 
Sport Med. 37: 436–440. 
99. Abe T, Kawakami Y, Suzuki Y, Gunji A, Fukunaga T (1997): Effects of 20 days bed rest on 
muscle morphology. J Gravit Physiol. 4: S10–4. 
100. Abe T, Patterson KM, Stover CD, Young KC (2015): Influence of adipose tissue mass on DXA-
derived lean soft tissue mass in middle-aged and older women. Age (Omaha). 37. doi: 
10.1007/s11357-014-9741-1. 
101. Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TTL, Kenny AM, et al. (2014): 
Cutpoints for low appendicular lean mass that identify older adults with clinically significant 
weakness. Journals Gerontol - Ser A Biol Sci Med Sci. 69 A: 567–575. 
102. Church TS, Thomas DM, Tudor-Locke C, Katzmarzyk PT, Earnest CP, Rodarte RQ, et al. 
(2011): Trends over 5 decades in U.S. occupation-related physical activity and their associations 
with obesity. PLoS One. 6: 1–7. 
103. Paris M, Mourtzakis M (2016): Assessment of skeletal muscle mass in critically ill patients: 
considerations for the utility of computed tomography imaging and ultrasonography. Curr Opin 
Clin Nutr Metab Care. In Press. 
104. Moseley A, Adams R (1991): Measurement of passive ankle dorsiflexion: Procedure and 
reliability. Aust J Physiother. 37: 175–81. 
105. James WPT, Chunming C, Inoue S (2002): Appropriate Asian body mass indices? Obes Rev. 3: 
  76 
139. 
106. Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM, Kim JH (2016): Evaluation of 
sarcopenia in small-cell lung cancer patients by routine chest CT. Support Care Cancer. 0–5. 
107. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. (2003): 
Sarcopenia: Alternative Definitions and Associations with Lower Extremity Function. J Am 
Geriatr Soc. 51: 1602–1609. 
108. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, et al. (2007): 
Alternative definitions of sarcopenia, lower extremity performance, and functional impairment 
with aging in older men and women. J Am Geriatr Soc. 55: 769–774. 
109. Walker DK, Thaden JJ, Deutz NEP (2015): Application of gas chromatography-tandem mass 
spectrometry (GC/MS/MS) for the analysis of deuterium enrichment of water. J Mass Spectrom. 
50: 838–843. 
110. Utter AC, Hager ME (2008): Evaluation of ultrasound in assessing body composition of high 
school wrestlers. Med Sci Sports Exerc. 40: 943–949. 
111. Smith-Ryan AE, Fultz SN, Melvin MN, Wingfield HL, Woessner MN (2014): Reproducibility 
and validity of A-mode ultrasound for body composition measurement and classification in 
overweight and obese men and women. PLoS One. 9. doi: 10.1371/journal.pone.0091750. 
112. Roelofs EJ, Smith-Ryan AE, Melvin MN, Wingfield HL, Trexler ET, Walker N (2015): Muscle 
size, quality, and body composition: characteristics of division I cross-country runners. J 
strength Cond Res / Natl Strength Cond  Assoc. 29: 290–296. 
113. Johnson KE, Miller B, Gibson AL, McLain TA, Juvancic-Heltzel JA, Kappler RM, Otterstetter 
R (2016): A comparison of dual-energy X-ray absorptiometry, air displacement 
plethysmography and A-mode ultrasound to assess body composition in college-age adults. Clin 
Physiol Funct Imaging. . doi: 10.1111/cpf.12351. 
 
  77 
Appendix 
Appendix A1. Comparison of multiple body composition modalities 
Modality 
 
Fundamental 
Principle 
Advantages Disadvantages References 
DXA Uses 2 different 
energy x-ray beams 
to differentiate soft 
tissue and bone. 
Adipose tissue and 
lean soft tissue are 
further differentiated 
based on attenuation 
factors of the tissues. 
Differentiates body 
into 3 compartments 
(adipose, lean and 
bone tissue). 
Can obtain whole 
body, regional and 
segment specific 
measures. 
Low dose radiation 
x-rays allows for 
safe repeated 
measures 
High accuracy and 
repeatability  
 
Cannot further 
differentiate adipose 
(subcutaneous, 
visceral, and 
intramuscular) and 
lean tissue (muscle, 
organs, connective 
tissue). 
 Not safe for pregnant 
women due to 
radiation exposure 
 
(5; 32) 
CT Uses attenuation 
coefficients of x-rays 
that pass through 
tissues. Attenuation 
is based on different 
density of tissues 
and cross-sectional 
images are produced. 
Highly accurate and 
reliable quantitative 
measures of body 
composition (muscle 
and adipose tissue) 
Can differentiate 
between 
intramuscular, 
subcutaneous and 
visceral adipose 
tissue. 
 
Large radiation 
exposure – generally 
limited to quantifying 
images take as part of 
routine care 
High cost and 
technical skills 
required to operate 
(5; 18) 
MRI Strong magnetic 
field is generated 
and hydrogen atoms 
in tissues align with 
magnetic field. 
Aligned hydrogen 
atoms are activated 
via a radio frequency 
signal and the 
subsequent decay 
signal is used to 
generate cross-
sectional images. 
 
Safe for all ages – no 
radiation exposure 
Very high image 
resolution 
Accurate measures 
of muscle mass, 
intramuscular, 
visceral and 
subcutaneous 
adipose tissue 
High cost and 
technical skills 
required to operate 
Limited availability 
(5; 18) 
BIA Alternating electrical 
current is passed 
through proximal 
and distal electrodes, 
Widely available, 
safe for all ages, no 
technical expertise 
required 
Requires population 
specific equations 
Limited applicability 
in obese patients 
(5) 
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the voltage drop is 
measured. Fat-free 
mass has higher 
water and electrolyte 
content and allows 
easier transmission 
of current. 
 
High variability in fat-
free mass estimations 
 
Hydrostatic weight 
and air displacement 
plethysmography 
Body volume is 
measured using 
relationships 
between pressure 
and volume. Body 
volume and weight 
are used to calculate 
body density. 
 
Very precise and 
accurate for 
assessment of body 
fat.  
Easily 
accommodates most 
individuals. 
Questionable validity 
for fat-free mass 
estimates 
Less widely available 
(5) 
 
Deuterium oxide 
dilution 
 
 
 
Volume of 
compartment is 
measured by 
assessing dilution of 
isotopically labelled 
water. Total body 
water is used to 
estimate fat-free 
mass 
 
Safe and easily 
applied during field 
research 
 
Several assumptions 
for tracer metabolism 
Assumed hydration 
status of fat-free mass 
Expensive 
(109) 
B-mode ultrasound High frequency 
sound waves are 
transmitted and 
partly reflected 
within tissues. 
Different tissues 
have different 
reflection 
coefficients. 
Reflected waves are 
detected and used to 
generate on screen 
images. 
Portable, no 
radiation exposure, 
lower cost relative to 
other modalities 
Accurate and reliable 
measures of cross 
sectional area or 
thickness of  
subcutaneous tissues 
 
Measures depend 
greatly on the operator 
(tissue depression, 
landmarking, tissue 
border identification) 
Hydration status 
and/or tissue swelling 
can confound 
measures 
No standardized 
protocol for 
assessment of tissues 
(33) 
BIA, bioelectrical impedance analysis; CT, computerized tomography; DXA, dual-energy x-ray absorptiometry; MRI, 
magnetic resonance imaging, MRI. 
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Appendix A2. Linear regression analysis to predict appendicular lean tissue using the 9-site protocol  
Model 
development 
Appendicular lean 
tissue prediction (kg) 
Cross-validation 
fold 
Unadjusted 
r2 
Adjusted 
r2 
SEE 
(kg) 
p-value 
model 
Folds 1+2 -4.320+(0.563X5) 3 0.92 0.92 1.53 <0.001 
Folds 1+3 -4.671+(0.569X5) 2 0.90 0.90 1.76 <0.001 
Folds 2+3 -5.155+(0.581X5) 1 0.89 0.89 1.89 <0.001 
Average -4.715+(0.571X5) - 0.90 0.90 1.73 - 
SEE, standard error of the estimate. X5 = 9 site muscle thickness x height (cm x m). 
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Appendix A3. 
 
Appendix A3. Bland-Altman plot comparing DXA derived and the 9-site protocol predicted appendicular lean tissue mass, 
utilizing all participants from all folds. No fixed (0.00 [-0.34, 0.35]) or proportional bias was present (solid black line, 95% 
CI – inner short dashed line), with limits of agreement (1.96 SD) of -3.32 and 3.32 (middle long dashed lines) and tolerance 
limits of -3.91 and 3.92 (outer short dashed lines). Crosses (×) represent fold 1, closed circles (●) represent fold 2, and open 
circles (○) represent fold 3. 
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Appendix A4. 
 
    Appendix A4. Demonstration of a non-ideal muscle thickness measured using the 4-site protocol. 
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Appendix A5. 
 
  
Appendix A5. Bland-Altman plots for intra-rater reliability using the 4-site protocol for minimal compression. Minimal 
compression average bias [95% CI] for all intra-rater plots (except plot with proportional bias) was -0.04 [-0.03, 0.01] with 
average limits of agreement and tolerance limits were -0.14 and 0.12 and -0.16 and 0.14.  
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Appendix A6. 
Appendix A6. Bland-Altman plots for intra-rater reliability using the 4-site protocol for maximal compression. Maximal 
compression presented a significant fixed bias of -0.02 [-0.04, -0.01] with average limits of agreement and tolerance limits 
were -0.14 and 0.12 and -0.16 and 0.14 and for maximal compression, -0.16 and 0.11 and -0.18 and 0.14.  
 
